RESULT_COUNT: 279,PAGE_SIZE: 10000,CURRENT_PAGE: 1,TOTAL_PAGES: 1,API_CALL_CREDITS: 1
TICKER,FIGI_TICKER,FIGI,TITLE,PUBLICATION_DATE,URL,SUMMARY
HAE,HAE:US,BBG000C7TF41,"ETFs with exposure to Haemonetics Corp. : October 20, 2017",2017-10-20 14:14:21 +0000,http://finance.yahoo.com/r/9fe8df58-37d5-3fba-9c33-494ff08fe3cc/etfs-with-exposure-to-haemonetics-corp-october-20-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Haemonetics Corp. Here are 5 ETFs with the largest exposure to HAE-US. Comparing the performance and risk of Haemonetics Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
<b>(Read more...)</b>"
HAE,HAE:US,BBG000C7TF41,Robert E. Abernathy Joins Haemonetics Board of Directors,2017-10-18 12:00:00 +0000,https://finance.yahoo.com/news/robert-e-abernathy-joins-haemonetics-120000635.html?.tsrc=rss,"BRAINTREE, Mass. , Oct. 18, 2017 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced the election of Robert E. Abernathy , a seasoned healthcare executive, to its Board of Directors. Mr. Abernathy ..."
HAE,HAE:US,BBG000C7TF41,"Haemonetics Sets Date for Publishing 2nd Quarter and 1st Half Fiscal 2018 Results: November 7, 2017",2017-10-10 20:26:00 +0000,https://finance.yahoo.com/news/haemonetics-sets-date-publishing-2nd-202600385.html?.tsrc=rss,"BRAINTREE, Mass. , Oct. 10, 2017 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company will publish second quarter and first half fiscal 2018 financial results at 6:00 am Eastern ..."
HAE,HAE:US,BBG000C7TF41,"ETFs with exposure to Haemonetics Corp. : October 9, 2017",2017-10-09 15:36:12 +0000,http://finance.yahoo.com/r/55b7552b-2f0f-3b61-be16-f8edd111c8c5/etfs-with-exposure-to-haemonetics-corp-october-9-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Haemonetics Corp. Here are 5 ETFs with the largest exposure to HAE-US. Comparing the performance and risk of Haemonetics Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
<b>(Read more...)</b>"
HAE,HAE:US,BBG000C7TF41,"Haemonetics Corp. :HAE-US: Earnings Analysis: Q1, 2018 By the Numbers : October 6, 2017",2017-10-06 13:02:53 +0000,http://finance.yahoo.com/r/0cc8c655-de09-3c7d-af17-ee7fc22af64f/haemonetics-corp-hae-us-earnings-analysis-q1-2018-by-the-numbers-october-6-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Haemonetics Corp. reports financial results for the quarter ended June 30, 2017. Highlights Summary numbers: Revenues of USD 210.95 million, Net Earnings of USD 20.14 million. Gross margins narrowed from 43.89% to 43.45% compared to the same period last year, operating (EBITDA) margins now 19.39% from 15.31%. Change in operating cash ... Read more
<b>(Read more...)</b>"
HAE,HAE:US,BBG000C7TF41,Haemonetics Shows Market Leadership With Jump To 81 RS Rating,2017-10-06 07:00:00 +0000,http://finance.yahoo.com/r/761801bb-7fc4-3e20-a0d5-08f60def1635/haemonetics-shows-market-leadership-with-jump-to-81-rs-rating?src=A00220&yptr=yahoo&.tsrc=rss,Haemonetics sees its Relative Strength Rating enter the 80-plus level.
HAE,HAE:US,BBG000C7TF41,Haemonetics Earns RS Rating Upgrade,2017-10-02 14:50:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7omBFIwgPs4/haemonetics-earns-rs-rating-upgrade-cm853946,Haemonetics HAE saw a welcome improvement to its Relative Strength RS Rating on Monday with an upgrade from 68 to 76 ibd display video id 449423 width 50 float left autostart true IBD s unique rating identifies price action with a 1 worst to 99 best
HAE,HAE:US,BBG000C7TF41,See what the IHS Markit Score report has to say about Haemonetics Corp.,2017-10-02 12:03:10 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120310283.html?.tsrc=rss,Haemonetics Corp NYSE:HAE
HAE,HAE:US,BBG000C7TF41,See what the IHS Markit Score report has to say about Haemonetics Corp.,2017-09-29 12:06:56 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120656019.html?.tsrc=rss,Haemonetics Corp NYSE:HAE
HAE,HAE:US,BBG000C7TF41,See what the IHS Markit Score report has to say about Haemonetics Corp.,2017-09-28 12:06:55 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120655262.html?.tsrc=rss,Haemonetics Corp NYSE:HAE
HAE,HAE:US,BBG000C7TF41,"Zacks.com featured highlights include Merck, Haemonetics, LKQ, Eastman Chemical and Honeywell International",2017-09-27 14:59:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NV0axOf73w0/zackscom-featured-highlights-include-merck-haemonetics-lkq-eastman-chemical-and-honeywell-international-cm851780,For Immediate Release Chicago IL September 27 2017 Stocks in this week s article include Merck amp Co 160 NYSE 160 MRK 160 Free Report Haemonetics NYSE 160 HAE 160 Free Report LKQ Corp Nasdaq 160 LKQ 160 Free Report Eastman Chemical
HAE,HAE:US,BBG000C7TF41,"Zacks.com featured highlights include Merck, Haemonetics, LKQ, Eastman Chemical and Honeywell International",2017-09-27 12:36:12 +0000,https://finance.yahoo.com/news/zacks-com-featured-highlights-merck-123612662.html?.tsrc=rss,"Zacks.com featured highlights include Merck, Haemonetics, LKQ, Eastman Chemical and Honeywell International"
HAE,HAE:US,BBG000C7TF41,Top Stocks with Big Potential Catch-Up Moves,2017-09-26 22:53:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ba2Sicqv8_8/top-stocks-with-big-potential-catch-up-moves-cm851434,Given the recent run up in the market here s a screen I ve been using recently for my own stock picking First it focuses on the top Zacks Ranked Sectors and Industries Then it focuses on the Zacks Rank 1s 2s and 3s which are Strong Buys Buys and Holds respectively But then it
HAE,HAE:US,BBG000C7TF41,See what the IHS Markit Score report has to say about Haemonetics Corp.,2017-09-25 12:02:28 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120636006.html?.tsrc=rss,Haemonetics Corp NYSE:HAE
HAE,HAE:US,BBG000C7TF41,Haemonetics Appoints David J. Wilson Plasma Business Unit President,2017-09-14 12:00:00 +0000,https://finance.yahoo.com/news/haemonetics-appoints-david-j-wilson-120000183.html?.tsrc=rss,"BRAINTREE, Mass. , Sept. 14, 2017 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced the appointment of David J. Wilson as President, Plasma Business Unit, effective September 18, 2017 . Mr. ..."
HAE,HAE:US,BBG000C7TF41,See what the IHS Markit Score report has to say about Haemonetics Corp.,2017-09-12 12:03:48 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120348848.html?.tsrc=rss,Haemonetics Corp NYSE:HAE
HAE,HAE:US,BBG000C7TF41,See what the IHS Markit Score report has to say about Haemonetics Corp.,2017-09-11 14:07:35 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120337275.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
HAE,HAE:US,BBG000C7TF41,See what the IHS Markit Score report has to say about Haemonetics Corp.,2017-09-06 14:09:22 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-140922101.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
HAE,HAE:US,BBG000C7TF41,See what the IHS Markit Score report has to say about Haemonetics Corp.,2017-09-04 12:03:57 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120357345.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
HAE,HAE:US,BBG000C7TF41,See what the IHS Markit Score report has to say about Haemonetics Corp.,2017-09-02 12:07:57 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120757691.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
HAE,HAE:US,BBG000C7TF41,"Haemonetics Grows on Strong Plasma, Blood Center Sluggish",2017-09-01 15:51:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NacEyg2ItaE/haemonetics-grows-on-strong-plasma-blood-center-sluggish-cm840242,On Sep 1 we issued an updated research report on Haemonetics Corporation HAE a Braintree MA based leading provider of blood management solutions to customers encompassing blood and plasma collectors plus hospitals and health care providers globally The stock currently carries a Zacks
HAE,HAE:US,BBG000C7TF41,"Haemonetics Grows on Strong Plasma, Blood Center Sluggish",2017-09-01 14:08:02 +0000,https://finance.yahoo.com/news/haemonetics-grows-strong-plasma-blood-140802167.html?.tsrc=rss,"Haemonetics&apos; (HAE) encouraging growth in both Plasma and Haemonetics Management franchises keeps the market upbeat. However, slow revenue growth at the Blood Center franchise raises concern."
HAE,HAE:US,BBG000C7TF41,Haemonetics to Present at Morgan Stanley's Global Healthcare Conference,2017-08-29 21:00:00 +0000,https://finance.yahoo.com/news/haemonetics-present-morgan-stanleys-global-210000249.html?.tsrc=rss,"BRAINTREE, Mass. , Aug. 29, 2017 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon , President and CEO, will present at Morgan Stanley's Global Healthcare Conference in New ..."
HAE,HAE:US,BBG000C7TF41,See what the IHS Markit Score report has to say about Haemonetics Corp.,2017-08-23 12:02:39 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120239674.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
HAE,HAE:US,BBG000C7TF41,"Medtronic (MDT) Beats Q1 Earnings, Misses Revenue Estimates",2017-08-22 22:38:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/e5cfDYM-_is/medtronic-mdt-beats-q1-earnings-misses-revenue-estimates-cm835664,Medtronic plc MDT reported financial results for first quarter fiscal 2018 Adjusted earnings per share EPS in the reported quarter came in at 1 12 surpassing the Zacks Consensus Estimate by 3 7 and up 8 7 year over year 160 Adjustments in the quarter primarily included certain
HAE,HAE:US,BBG000C7TF41,"Medtronic (MDT) Beats Q1 Earnings, Misses Revenue Estimates",2017-08-22 21:00:09 +0000,https://finance.yahoo.com/news/medtronic-mdt-beats-q1-earnings-210009228.html?.tsrc=rss,Medtronic (MDT) rides high in Q1 on strength in three major business segments.
HAE,HAE:US,BBG000C7TF41,"Haemonetics Plasma Arm Grows Strong, Blood Center Sluggish",2017-08-16 15:40:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tLMCYkFVaPs/haemonetics-plasma-arm-grows-strong-blood-center-sluggish-cm832796,On Aug 16 we issued an updated research report on Haemonetics Corporation HAE a Braintree MA based leading provider of blood management solutions to customers encompassing blood and plasma collectors hospitals and health care providers globally The stock currently carries a Zacks Rank
HAE,HAE:US,BBG000C7TF41,"Haemonetics Plasma Arm Grows Strong, Blood Center Sluggish",2017-08-16 13:40:01 +0000,https://finance.yahoo.com/news/haemonetics-plasma-arm-grows-strong-134001657.html?.tsrc=rss,"Haemonetics (HAE) registers strong top-line growth, banking on Plasma, TEG, hemostasis management as well as a strong cash position. Blood Center drag continues."
HAE,HAE:US,BBG000C7TF41,Cardiovascular Systems Unveils Favorable LIBERTY 360 Data,2017-08-15 15:41:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qEOx3Ry4_jA/cardiovascular-systems-unveils-favorable-liberty-360-data-cm832209,Medical device manufacturer Cardiovascular Systems Inc CSII recently released one year data from its LIBERTY 360 clinical study in a late breaking presentation 160 at the 2017 Amputation Prevention Symposium AMP in Chicago LIBERTY 360 is a prospective observational multi
HAE,HAE:US,BBG000C7TF41,"Zacks.com featured highlights: The Chemours Company, Haemonetics Corporation and The Brink's Company",2017-08-14 17:35:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0pfF907DHdA/zackscom-featured-highlights-the-chemours-company-haemonetics-corporation-and-the-brinks-company-cm831775,For Immediate Release Chicago IL August 14 2017 Stocks in this week s article include The Chemours Company NYSE CC Free Report Haemonetics Corporation NYSE HAE Free Report and The Brink s Company NYSE BCO Free Report 3 Best Stocks with Upgraded
HAE,HAE:US,BBG000C7TF41,"Zacks.com featured highlights: The Chemours Company, Haemonetics Corporation and The Brink&apos;s Company",2017-08-14 15:59:03 +0000,https://finance.yahoo.com/news/zacks-com-featured-highlights-chemours-155903015.html?.tsrc=rss,"Zacks.com featured highlights: The Chemours Company, Haemonetics Corporation and The Brink&apos;s Company"
HAE,HAE:US,BBG000C7TF41,Edited Transcript of HAE earnings conference call or presentation 7-Aug-17 12:00pm GMT,2017-08-12 13:35:57 +0000,https://finance.yahoo.com/news/edited-transcript-hae-earnings-conference-152731723.html?.tsrc=rss,Q1 2018 Haemonetics Corp Earnings Call
HAE,HAE:US,BBG000C7TF41,See what the IHS Markit Score report has to say about Haemonetics Corp.,2017-08-12 12:02:48 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120248767.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
HAE,HAE:US,BBG000C7TF41,3 Best Stocks with Upgraded Broker Ratings to Invest In Now,2017-08-11 12:37:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5xbbwUx66Jw/3-best-stocks-with-upgraded-broker-ratings-to-invest-in-now-cm830733,You must be thinking that investing in stocks is one of the easiest things to do But it s not as easy as it may seem For this one has to understand the fundamentals of a company and place them against the present economic background to figure out how it may fare as an investment One way
HAE,HAE:US,BBG000C7TF41,3 Best Stocks with Upgraded Broker Ratings to Invest In Now,2017-08-11 10:58:10 +0000,https://finance.yahoo.com/news/3-best-stocks-upgraded-broker-105810817.html?.tsrc=rss,"Selecting stocks from the vast investment universe is not an easy task. In such a situation, sound broker advice helps to pick the right stocks."
HAE,HAE:US,BBG000C7TF41,Haemonetics Banks on Solid Plasma & Haemonetics Management,2017-08-10 15:40:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1NGVmae5VGc/haemonetics-banks-on-solid-plasma-haemonetics-management-cm830182,On Aug 9 we issued an updated research report on 160 Haemonetics Corporation 160 HAE a Braintree MA based leading provider of blood management solutions to customers encompassing blood and plasma collectors hospitals and health care providers globally The stock currently carries a
HAE,HAE:US,BBG000C7TF41,Haemonetics Banks on Solid Plasma & Haemonetics Management,2017-08-10 13:53:01 +0000,https://finance.yahoo.com/news/haemonetics-banks-solid-plasma-haemonetics-135301033.html?.tsrc=rss,"Despite encouraging growth at the Plasma and Haemonetics Management franchises, the underperformance at the BloodCenter franchisee was quite a dampener for Haemonetics (HAE)."
HAE,HAE:US,BBG000C7TF41,See what the IHS Markit Score report has to say about Haemonetics Corp.,2017-08-10 12:07:29 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120729503.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
HAE,HAE:US,BBG000C7TF41,"Haemonetics (HAE) Q1 Earnings Beat, Revenues Miss Estimates",2017-08-08 13:38:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ci83AH-Q0VI/haemonetics-hae-q1-earnings-beat-revenues-miss-estimates-cm828693,Haemonetics Corporation 160 HAE reported adjusted earnings per share EPS of 33 cents in the first quarter of fiscal 2018 up 32 year over year The figure also beat the Zacks Consensus Estimate of 31 cents On a reported basis Haemonetics posted net income of 20 1 million or 38 cents
HAE,HAE:US,BBG000C7TF41,"Haemonetics (HAE) Q1 Earnings Beat, Revenues Miss Estimates",2017-08-08 12:31:12 +0000,https://finance.yahoo.com/news/haemonetics-hae-q1-earnings-beat-123112531.html?.tsrc=rss,Haemonetics (HAE) rides high on Plasma and Haemonetics Management franchises strength in Q1.
HAE,HAE:US,BBG000C7TF41,Haemonetics tops 1Q profit forecasts,2017-08-08 03:58:03 +0000,https://finance.yahoo.com/news/haemonetics-tops-1q-profit-forecasts-101143547.html?.tsrc=rss,"The Braintree, Massachusetts-based company said it had profit of 38 cents per share. Earnings, adjusted for one-time gains and costs, came to 33 cents per share. The results surpassed Wall Street expectations. ..."
HAE,HAE:US,BBG000C7TF41,Haemonetics 1st Quarter Fiscal 2018 Earnings Release Available on Investor Relations Website,2017-08-07 10:00:00 +0000,https://finance.yahoo.com/news/haemonetics-1st-quarter-fiscal-2018-100000136.html?.tsrc=rss,"Financial release accessible online BRAINTREE, Mass. , Aug. 7, 2017 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that first quarter fiscal 2018 financial results are available on its Investor ..."
HAE,HAE:US,BBG000C7TF41,"Haemonetics Posts Profit In Q1, Above Market; Revenues Miss Estimates",2017-08-07 06:25:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VqL9qyPIacA/haemonetics-posts-profit-in-q1-above-market-revenues-miss-estimates-20170807-00189,"Haemonetics Posts Profit In Q1, Above Market; Revenues Miss Estimates"
HAE,HAE:US,BBG000C7TF41,"Haemonetics Corp. – Value Analysis (NYSE:HAE) : August 5, 2017",2017-08-05 00:46:29 +0000,http://finance.yahoo.com/r/182da910-9662-33aa-ae9b-c7f6aa0688ee/haemonetics-corp-value-analysis-nysehae-august-5-2017?yptr=yahoo&.tsrc=rss,"Categories:  Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Haemonetics Corp. a score of 28. Our analysis is based on comparing Haemonetics Corp. with the following peers – Thermo Fisher Scientific Inc., Stryker Corporation, Becton, Dickinson and Company, C. R. Bard, Inc., Cerus Corporation, Baxter International Inc., PerkinElmer, Inc., Cytori Therapeutics, Inc., HemaCare Corporation and Johnson ... Read more
<b>(Read more...)</b>"
HAE,HAE:US,BBG000C7TF41,"Pre-Market Earnings Report for August 7, 2017 :  TSN, FDC, ON, BAH, DCP, GEO, KOS, IIVI, HAE, FOLD, HZNP, FI",2017-08-04 20:18:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aj-Wgxxp6IA/pre-market-earnings-report-for-august-7-2017-tsn-fdc-on-bah-dcp-geo-kos-iivi-hae-fold-hznp-fi-cm827533,The following companies are expected to report earnings prior to market open on 08 07 2017 Visit our Earnings Calendar for a full list of expected earnings releases Tyson Foods Inc TSN is reporting for the quarter ending June 30 2017 The meat
HAE,HAE:US,BBG000C7TF41,Why Earnings Season Could Be Great for Haemonetics (HAE),2017-08-03 14:03:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lEebaiSkgR0/why-earnings-season-could-be-great-for-haemonetics-hae-cm826439,Investors are always looking for stocks that are poised to beat at earnings season and Haemonetics Corporation HAE may be one such company The firm has earnings coming up pretty soon and events are shaping up quite nicely for their report That is because Haemoneticsis seeing
HAE,HAE:US,BBG000C7TF41,Why Earnings Season Could Be Great for Haemonetics (HAE),2017-08-03 12:37:12 +0000,https://finance.yahoo.com/news/why-earnings-season-could-great-123712978.html?.tsrc=rss,Haemonetics (HAE) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP ahead of earnings.
HAE,HAE:US,BBG000C7TF41,Can PerkinElmer (PKI) Spring a Surprise in Q2 Earnings?,2017-08-01 13:59:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/I_kJymVTrQg/can-perkinelmer-pki-spring-a-surprise-in-q2-earnings-cm824773,Headquartered in Waltham MA PerkinElmer Inc PKI provides scientific instruments consumables and services to pharmaceutical biomedical environmental testing chemical and general industrial markets worldwide The company is expected to release second quarter fiscal 2017 results on Aug
HAE,HAE:US,BBG000C7TF41,Featured Company News - Haemonetics Announces FDA Clearance for its NexSys PCS; Set to Reduce Cost per Liter of Plasma Collected,2017-07-31 11:40:00 +0000,https://finance.yahoo.com/news/featured-company-news-haemonetics-announces-114000011.html?.tsrc=rss,"Research Desk Line-up: C. R. Bard Post Earnings Coverage LONDON, UK / ACCESSWIRE / July 31, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Haemonetics ..."
HAE,HAE:US,BBG000C7TF41,"DVAX Surges On FDA Panel Vote, CYTR On Watch, EC Approves New HCV Drugs",2017-07-30 23:37:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VyMvNbBE49g/dvax-surges-on-fda-panel-vote-cytr-on-watch-ec-approves-new-hcv-drugs-20170730-00113,"DVAX Surges On FDA Panel Vote, CYTR On Watch, EC Approves New HCV Drugs"
HAE,HAE:US,BBG000C7TF41,"DVAX Surges On FDA Panel Vote, CYTR On Watch, EU Approves New HCV Drugs",2017-07-30 23:33:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eEcCJR3rP0k/dvax-surges-on-fda-panel-vote-cytr-on-watch-eu-approves-new-hcv-drugs-20170730-00107,"DVAX Surges On FDA Panel Vote, CYTR On Watch, EU Approves New HCV Drugs"
HAE,HAE:US,BBG000C7TF41,Haemonetics Announces FDA Clearance of New Plasmapheresis System Branded NexSys PCS™,2017-07-28 12:30:00 +0000,https://finance.yahoo.com/news/haemonetics-announces-fda-clearance-plasmapheresis-123000280.html?.tsrc=rss,"BRAINTREE, Mass., July 28, 2017 /PRNewswire/ -- Haemonetics Corporation (HAE) has received FDA 510(k) clearance for its NexSys PCS™ plasmapheresis system.  The NexSys PCS includes bi-directional connectivity to Haemonetics' donor management system, NexLynk DMS™, and builds on Haemonetics' industry leading position with a design inspired by extensive user research."
HAE,HAE:US,BBG000C7TF41,"Haemonetics Corp. breached its 50 day moving average in a Bearish Manner : HAE-US : July 24, 2017",2017-07-24 13:33:02 +0000,http://finance.yahoo.com/r/713c744e-cc17-3b97-938d-604088617589/haemonetics-corp-breached-its-50-day-moving-average-in-a-bearish-manner-hae-us-july-24-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Haemonetics Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more
<b>(Read more...)</b>"
HAE,HAE:US,BBG000C7TF41,"Haemonetics Sets Date for Publishing 1st Quarter Fiscal 2018 Results: August 7, 2017",2017-07-18 12:00:00 +0000,https://finance.yahoo.com/news/haemonetics-sets-date-publishing-1st-120000037.html?.tsrc=rss,"BRAINTREE, Mass. , July 18, 2017 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company will publish first quarter fiscal 2018 financial results at 6:00am Eastern Time on Monday, ..."
HAE,HAE:US,BBG000C7TF41,"Haemonetics Plasma Arm Advances, Blood Center Sluggish",2017-07-17 22:48:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/j-DWjJt01lY/haemonetics-plasma-arm-advances-blood-center-sluggish-cm817189,On Jul 13 we issued an updated research report on Haemonetics Corporation HAE a Braintree MA based leading provider of blood management solutions to customers encompassing blood and plasma collectors hospitals and health care providers globally The stock currently carries a Zacks Rank
HAE,HAE:US,BBG000C7TF41,"Haemonetics Plasma Arm Advances, Blood Center Sluggish",2017-07-17 20:22:08 +0000,https://finance.yahoo.com/news/haemonetics-plasma-arm-advances-blood-202208738.html?.tsrc=rss,"On Jul 13, we issued an updated research report on Haemonetics Corporation (HAE)."
HAE,HAE:US,BBG000C7TF41,Believe In The Haemonetics Turnaround Story; JMP Upgrades To Market Outperform,2017-07-13 16:58:36 +0000,https://finance.yahoo.com/news/believe-haemonetics-turnaround-story-jmp-165836140.html?.tsrc=rss,"Shares of Haemonetics Corporation (NYSE: HAE ), a provider of products to customers involved in the processing, handling and analysis of blood, gained more than 4 percent Thursday morning after analysts ..."
HAE,HAE:US,BBG000C7TF41,"ETFs with exposure to Haemonetics Corp. : July 6, 2017",2017-07-06 17:54:23 +0000,http://finance.yahoo.com/r/1d8cc1cc-21ae-3abe-82e3-aa0ff0dab9bd/etfs-with-exposure-to-haemonetics-corp-july-6-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Haemonetics Corp. Here are 5 ETFs with the largest exposure to HAE-US. Comparing the performance and risk of Haemonetics Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
<b>(Read more...)</b>"
HAE,HAE:US,BBG000C7TF41,Haemonetics Announces Formation of Scientific Advisory Council,2017-06-22 20:58:00 +0000,https://finance.yahoo.com/news/haemonetics-announces-formation-scientific-advisory-205800542.html?.tsrc=rss,"BRAINTREE, Mass. , June 22, 2017 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced the formation of a Scientific Advisory Council (""SAC"") as part of its broader innovation agenda, ..."
HAE,HAE:US,BBG000C7TF41,"Haemonetics Rides on Solid Plasma, Slows Blood Center Growth",2017-06-14 22:06:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/W1MXA-QW8bw/haemonetics-rides-on-solid-plasma-slows-blood-center-growth-cm803549,On Jun 13 we issued an updated research report on Haemonetics Corporation HAE a Braintree MA based leading provider of blood management solutions to customers encompassing blood and plasma collectors hospitals and health care providers globally For the past three months Haemonetics
HAE,HAE:US,BBG000C7TF41,"Haemonetics Rides on Solid Plasma, Slows Blood Center Growth",2017-06-14 20:11:08 +0000,https://finance.yahoo.com/news/haemonetics-rides-solid-plasma-slows-201108607.html?.tsrc=rss,"On Jun 13, we issued an updated research report on Haemonetics Corporation (HAE)."
HAE,HAE:US,BBG000C7TF41,Haemonetics Will Webcast Investor and Analyst Meeting,2017-06-14 20:00:00 +0000,https://finance.yahoo.com/news/haemonetics-webcast-investor-analyst-meeting-200000659.html?.tsrc=rss,"BRAINTREE, Mass. , June 14, 2017 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) will webcast the management presentations and the question and answer period of its investor and analyst meeting on ..."
HAE,HAE:US,BBG000C7TF41,"Haemonetics Corp. :HAE-US: Earnings Analysis: Q4, 2017 By the Numbers : June 14, 2017",2017-06-14 13:33:33 +0000,http://finance.yahoo.com/r/3bcd7f7b-2775-33ae-b00e-ea73c213f55f/haemonetics-corp-hae-us-earnings-analysis-q4-2017-by-the-numbers-june-14-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Haemonetics Corp. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Haemonetics Corp. – Thermo Fisher Scientific Inc., Stryker Corporation, Becton, Dickinson and Company, C. R. Bard, Inc., Cerus Corporation, Baxter International Inc., PerkinElmer, Inc., Cytori Therapeutics, Inc. and Johnson ... Read more
<b>(Read more...)</b>"
HAE,HAE:US,BBG000C7TF41,"ETFs with exposure to Haemonetics Corp. : June 13, 2017",2017-06-13 16:33:45 +0000,http://finance.yahoo.com/r/14353029-06fd-36da-99ee-8424341a75e6/etfs-with-exposure-to-haemonetics-corp-june-13-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Haemonetics Corp. Here are 5 ETFs with the largest exposure to HAE-US. Comparing the performance and risk of Haemonetics Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
<b>(Read more...)</b>"
HAE,HAE:US,BBG000C7TF41,"Haemonetics Corp. breached its 50 day moving average in a Bearish Manner : HAE-US : June 13, 2017",2017-06-13 12:53:05 +0000,http://finance.yahoo.com/r/9d75824c-691a-3a80-9465-af82803198f0/haemonetics-corp-breached-its-50-day-moving-average-in-a-bearish-manner-hae-us-june-13-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Haemonetics Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more
<b>(Read more...)</b>"
HAE,HAE:US,BBG000C7TF41,Haemonetics (HAE) Down 2.2% Since Earnings Report: Can It Rebound?,2017-06-13 09:27:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3Vul038Wh_E/haemonetics-hae-down-22-since-earnings-report-can-it-rebound-cm802421,A month has gone by since the last earnings report for Haemonetics Corporation HAE Shares have lost about 2 2 in that time frame underperforming the market Will the recent negative trend continue leading up to the stock s next earnings release or is it due for a breakout Before we
HAE,HAE:US,BBG000C7TF41,Haemonetics (HAE) Down 2.2% Since Earnings Report: Can It Rebound?,2017-06-13 07:47:07 +0000,https://finance.yahoo.com/news/haemonetics-hae-down-2-2-074707685.html?.tsrc=rss,Haemonetics (HAE) reported earnings 30 days ago. What&apos;s next for the stock? We take a look at earnings estimates for some clues.
HAE,HAE:US,BBG000C7TF41,"Down 24.6%, is BioCryst Pharmaceuticals Stock Now a Buy?",2017-06-06 17:19:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YjVExkj-fnk/down-246-is-biocryst-pharmaceuticals-stock-now-a-buy-cm799495,What happened Shares of the rare disease drugmaker BioCryst Pharmaceuticals NASDAQ BCRX took investors on quite the ride last month After shooting higher by as much as 44 in a single day the biotech s shares ultimately ended the month down by a hefty 24
HAE,HAE:US,BBG000C7TF41,"ETFs with exposure to Haemonetics Corp. : May 30, 2017",2017-05-30 16:29:54 +0000,http://finance.yahoo.com/r/38e22568-5721-358f-8b36-1d6cda4f83f4/etfs-with-exposure-to-haemonetics-corp-may-30-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Haemonetics Corp. Here are 5 ETFs with the largest exposure to HAE-US. Comparing the performance and risk of Haemonetics Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
<b>(Read more...)</b>"
HAE,HAE:US,BBG000C7TF41,"Haemonetics Corp. breached its 50 day moving average in a Bullish Manner : HAE-US : May 29, 2017",2017-05-29 12:09:52 +0000,http://finance.yahoo.com/r/d081460e-4a53-303d-bb5f-f1bee30eea62/haemonetics-corp-breached-its-50-day-moving-average-in-a-bullish-manner-hae-us-may-29-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Haemonetics Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average ... Read more
<b>(Read more...)</b>"
HAE,HAE:US,BBG000C7TF41,"Haemonetics Corp. :HAE-US: Earnings Analysis: 2017 By the Numbers : May 26, 2017",2017-05-26 14:18:09 +0000,http://finance.yahoo.com/r/f801edcc-84a3-3d48-a7a0-47729f82d9be/haemonetics-corp-hae-us-earnings-analysis-2017-by-the-numbers-may-26-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Haemonetics Corp. reports financial results for the year ended March 31, 2017. We analyze the earnings along side the following peers of Haemonetics Corp. – Thermo Fisher Scientific Inc., Stryker Corporation, Becton, Dickinson and Company, C. R. Bard, Inc., Cerus Corporation, Baxter International Inc., PerkinElmer, Inc., Cytori Therapeutics, Inc. and Johnson ... Read more
<b>(Read more...)</b>"
HAE,HAE:US,BBG000C7TF41,Why BioCryst Pharmaceuticals Stock Caught Fire Today,2017-05-25 20:33:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fZOO51ot9I0/why-biocryst-pharmaceuticals-stock-caught-fire-today-cm794819,What happened Shares of the rare disease drugmaker BioCryst Pharmaceuticals NASDAQ BCRX gained as much as 44 today in early morning trading on sky high volume The catalyst behind this surge higher is the news that the company s experimental hereditary angioedema HAE
HAE,HAE:US,BBG000C7TF41,"Haemonetics Corp (HAE) Files 10-K for the Fiscal Year Ended on March 31, 2017",2017-05-24 21:48:03 +0000,https://finance.yahoo.com/news/haemonetics-corp-hae-files-10-214803456.html?.tsrc=rss,"Haemonetics Corp (NYSE:HAE) files its latest 10-K with SEC for the fiscal year ended on March 31, 2017."
HAE,HAE:US,BBG000C7TF41,"Haemonetics Sets Date for Investor / Analyst Meeting - June 19, 2017",2017-05-22 20:01:00 +0000,https://finance.yahoo.com/news/haemonetics-sets-date-investor-analyst-200100246.html?.tsrc=rss,"BRAINTREE, Mass., May 22, 2017 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that it will host an investor and analyst meeting on Monday, June 19 th from 10:00am to 2:00pm Eastern Time ..."
HAE,HAE:US,BBG000C7TF41,"Haemonetics Corp. – Value Analysis (NYSE:HAE) : May 19, 2017",2017-05-19 18:29:15 +0000,http://finance.yahoo.com/r/42c38623-0bf4-3c46-847b-3cda70e89067/haemonetics-corp-value-analysis-nysehae-may-19-2017?yptr=yahoo&.tsrc=rss,"Categories:  Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Haemonetics Corp. a score of 21. Our analysis is based on comparing Haemonetics Corp. with the following peers – Thermo Fisher Scientific Inc., Stryker Corporation, Becton, Dickinson and Company, C. R. Bard, Inc., Cerus Corporation, Baxter International Inc., PerkinElmer, Inc., Cytori Therapeutics, Inc., HemaCare Corporation and Johnson ... Read more
<b>(Read more...)</b>"
HAE,HAE:US,BBG000C7TF41,"Haemonetics Corp. breached its 50 day moving average in a Bearish Manner : HAE-US : May 18, 2017",2017-05-18 12:39:13 +0000,http://finance.yahoo.com/r/f77dfd92-fbaa-37ce-9af2-73e321da7dea/haemonetics-corp-breached-its-50-day-moving-average-in-a-bearish-manner-hae-us-may-18-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Haemonetics Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average ... Read more
<b>(Read more...)</b>"
HAE,HAE:US,BBG000C7TF41,Edited Transcript of HAE earnings conference call or presentation 8-May-17 12:00pm GMT,2017-05-12 21:26:02 +0000,https://finance.yahoo.com/news/edited-transcript-hae-earnings-conference-211616201.html?.tsrc=rss,Q4 2017 Haemonetics Corp Earnings Call
HAE,HAE:US,BBG000C7TF41,"Haemonetics (HAE) Tops Q4 Earnings, Sales, Issues 2018 View",2017-05-09 16:06:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Zw7LiltVsa8/haemonetics-hae-tops-q4-earnings-sales-issues-2018-view-cm786554,Haemonetics Corporation HAE reported adjusted earnings per share EPS of 39 cents in the fourth quarter of fiscal 2017 up 5 4 year over year The figure also beat the Zacks Consensus Estimate by the same margin On a reported basis Haemonetics posted net loss of 51 1 million or 98 cents
HAE,HAE:US,BBG000C7TF41,"Haemonetics (HAE) Tops Q4 Earnings, Sales, Issues 2018 View",2017-05-09 13:33:01 +0000,http://finance.yahoo.com/news/haemonetics-hae-tops-q4-earnings-133301702.html?.tsrc=rss,"Haemonetics Corporation (HAE) reported adjusted earnings per share (EPS) of 39 cents in the fourth quarter of fiscal 2017, up 5.4% year over year."
HAE,HAE:US,BBG000C7TF41,Edited Transcript of HAE earnings conference call or presentation 8-May-17 12:00pm GMT,2017-05-09 12:05:59 +0000,http://finance.yahoo.com/news/edited-transcript-hae-earnings-conference-211616201.html?.tsrc=rss,Q4 2017 Haemonetics Corp Earnings Call
HAE,HAE:US,BBG000C7TF41,Haemonetics reports 4Q loss,2017-05-08 10:34:30 +0000,http://finance.yahoo.com/news/haemonetics-reports-4q-loss-103430065.html?.tsrc=rss,"On a per-share basis, the Braintree, Massachusetts-based company said it had a loss of 98 cents. Earnings, adjusted for one-time gains and costs, came to 39 cents per share. The results surpassed Wall ..."
HAE,HAE:US,BBG000C7TF41,Haemonetics 4th Quarter and Fiscal Year 2017 Earnings Release and Fiscal Year 2018 Guidance Available on Investor Relations Website,2017-05-08 10:00:00 +0000,http://finance.yahoo.com/news/haemonetics-4th-quarter-fiscal-2017-100000988.html?.tsrc=rss,"BRAINTREE, Mass., May 8, 2017 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that fourth quarter and fiscal year 2017 financial results and fiscal 2018 guidance are available on its Investor ..."
HAE,HAE:US,BBG000C7TF41,Haemonetics Q4 Profit Tops Estimates - Quick Facts,2017-05-08 06:23:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dqnKwFx4_8Y/haemonetics-q4-profit-tops-estimates--quick-facts-20170508-00202,Haemonetics Q4 Profit Tops Estimates - Quick Facts
HAE,HAE:US,BBG000C7TF41,[$$] The Add-On Deal Roundup: April 28,2017-04-28 22:29:43 +0000,http://finance.yahoo.com/r/681be8ae-6ada-369b-a053-37a849027d3c/the-add-on-deal-roundup-april-28-1493418579?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,The following is a roundup of add-on acquisitions for private equity-backed companies.
HAE,HAE:US,BBG000C7TF41,"Haemonetics Sets Date for Publishing 4th Quarter and Full Fiscal Year 2017 Results and for Providing Fiscal 2018 Guidance: May 8, 2017",2017-04-26 20:01:00 +0000,http://finance.yahoo.com/news/haemonetics-sets-date-publishing-4th-200100878.html?.tsrc=rss,"BRAINTREE, Mass., April 26, 2017 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company will publish fourth quarter and full fiscal year 2017 financial results, and will provide ..."
HAE,HAE:US,BBG000C7TF41,"Haemonetics' Plasma Group Strong, Blood Center Group a Drag",2017-04-12 15:59:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/f5IBbA8egDg/haemonetics-plasma-group-strong-blood-center-group-a-drag-cm773275,On Apr 11 we issued an updated research report on Braintree MA based Haemonetics Corporation HAE a leading provider of blood management solutions to customers encompassing blood and plasma collectors hospitals and health care providers globally Haemonetics has been witnessing
HAE,HAE:US,BBG000C7TF41,"Haemonetics&apos; Plasma Group Strong, Blood Center Group a Drag",2017-04-12 13:36:01 +0000,http://finance.yahoo.com/news/haemonetics-apos-plasma-group-strong-133601186.html?.tsrc=rss,"On Apr 11, we issued an updated research report on Braintree, MA-based Haemonetics Corporation (HAE), a leading provider of blood management solutions."
HAE,HAE:US,BBG000C7TF41,"Haemonetics Corp. breached its 50 day moving average in a Bullish Manner : HAE-US : March 24, 2017",2017-03-24 12:06:52 +0000,http://finance.yahoo.com/r/96c9bf7d-bbd3-3d35-b1ea-0746d9cd85fe/haemonetics-corp-breached-its-50-day-moving-average-in-a-bullish-manner-hae-us-march-24-2017?yptr=yahoo&.tsrc=rss,"Categories:   ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Haemonetics Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average ... Read more    
<b>(Read more...)</b>"
HAE,HAE:US,BBG000C7TF41,"Haemonetics Corp. breached its 50 day moving average in a Bullish Manner : HAE-US : March 24, 2017",2017-03-24 12:06:52 +0000,http://www.capitalcube.com/blog/index.php/haemonetics-corp-breached-its-50-day-moving-average-in-a-bullish-manner-hae-us-march-24-2017/,"Haemonetics Corp. breached its 50 day moving average in a Bullish Manner : HAE-US : March 24, 2017"
HAE,HAE:US,BBG000C7TF41,Why Is Haemonetics (HAE) Up 3.5% Since the Last Earnings Report?,2017-03-09 09:14:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AXdg6MkNMoo/why-is-haemonetics-hae-up-35-since-the-last-earnings-report-cm758281,A month has gone by since the last earnings report for Haemonetics Corporation HAE Shares have added about 3 5 in that time frame outperforming the market Will the recent positive trend continue leading up to the stock s next earnings release or is it due for a pullback Before we
HAE,HAE:US,BBG000C7TF41,Why Is Haemonetics (HAE) Up 3.5% Since the Last Earnings Report?,2017-03-09 07:36:07 +0000,http://finance.yahoo.com/news/why-haemonetics-hae-3-5-073607364.html?.tsrc=rss,Haemonetics (HAE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
HAE,HAE:US,BBG000C7TF41,Why Is Haemonetics (HAE) Up 3.5% Since the Last Earnings Report?,2017-03-09 07:36:07 +0000,http://finance.yahoo.com/news/why-haemonetics-hae-3-5-073607364.html,Why Is Haemonetics (HAE) Up 3.5% Since the Last Earnings Report?
HAE,HAE:US,BBG000C7TF41,"The Reason Behind BioCryst Pharmaceuticals, Inc.'s 12% Pop Higher",2017-03-08 23:13:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IwPVxIsN7Bo/the-reason-behind-biocryst-pharmaceuticals-incs-12-pop-higher-cm758158,What happened Shares of BioCryst Pharmaceuticals NASDAQ BCRX a biotech company that develops small molecule drugs to block enzymes involved in disease proliferation surged as much as 12 today after a report was issued that a highly pathogenic H5N1 bird flu was found in
HAE,HAE:US,BBG000C7TF41,RBC Says These Top Health Care Stocks Could Be 2017 Takeover Candidates,2017-03-02 13:25:19 +0000,http://finance.yahoo.com/news/rbc-says-top-health-care-132519238.html?.tsrc=rss,"Each year, the analysts at RBC come out with a detailed list of smaller companies they feel are targets for acquisitions. These four health care candidates look extremely attractive."
HAE,HAE:US,BBG000C7TF41,RBC Says These Top Health Care Stocks Could Be 2017 Takeover Candidates,2017-03-02 13:25:19 +0000,http://finance.yahoo.com/news/rbc-says-top-health-care-132519238.html,RBC Says These Top Health Care Stocks Could Be 2017 Takeover Candidates
HAE,HAE:US,BBG000C7TF41,Here's Why BioCryst Pharmaceuticals Inc. Catapulted Higher by as Much as 17%,2017-02-28 23:12:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YfwIRXpsb6Y/heres-why-biocryst-pharmaceuticals-inc-catapulted-higher-by-as-much-as-17-cm754544,What happened Shares of BioCryst Pharmaceuticals NASDAQ BCRX a biopharmaceutical company primarily focused on the development of small molecule drugs that block enzymes associated with the development of diseases catapulted higher by as much as 17 during Tuesday s
HAE,HAE:US,BBG000C7TF41,HAEMONETICS CORP Financials,2017-02-10 18:04:20 +0000,http://finance.yahoo.com/q/is?s=hae,HAEMONETICS CORP Financials
HAE,HAE:US,BBG000C7TF41,Quotient Limited Announces Appointment of Christopher Lindop as Chief Financial Officer,2017-02-09 21:05:00 +0000,http://finance.yahoo.com/news/quotient-limited-announces-appointment-christopher-210500380.html?.tsrc=rss,"JERSEY, Channel Islands, Feb. 09, 2017-- Quotient Limited, a commercial-stage diagnostics company, today announced the appointment of Christopher Lindop as Chief Financial Officer. Lindop will commence ..."
HAE,HAE:US,BBG000C7TF41,Quotient Limited Announces Appointment of Christopher Lindop as Chief Financial Officer,2017-02-09 21:05:00 +0000,http://finance.yahoo.com/news/quotient-limited-announces-appointment-christopher-210500380.html,"[GlobeNewswire] - JERSEY, Channel Islands, Feb. 09, 2017-- Quotient Limited, a commercial-stage diagnostics company, today announced the appointment of Christopher Lindop as Chief Financial Officer. Lindop will commence ..."
HAE,HAE:US,BBG000C7TF41,"Haemonetics Corp. :HAE-US: Earnings Analysis: Q3, 2017 By the Numbers : February 9, 2017",2017-02-09 16:36:11 +0000,http://finance.yahoo.com/r/7c47ee64-9bf8-3716-b916-dd0a59352567/haemonetics-corp-hae-us-earnings-analysis-q3-2017-by-the-numbers-february-9-2017?yptr=yahoo&.tsrc=rss,"Categories:   Yahoo Finance Get free summary analysis Haemonetics Corp. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Haemonetics Corp. – Thermo Fisher Scientific Inc., Stryker Corporation, Becton, Dickinson and Company, C. R. Bard, Inc., Baxter International Inc. and PerkinElmer, Inc. (TMO-US, SYK-US, BDX-US, BCR-US, BAX-US and ... Read more    
<b>(Read more...)</b>"
HAE,HAE:US,BBG000C7TF41,"Haemonetics Corp. :HAE-US: Earnings Analysis: Q3, 2017 By the Numbers : February 9, 2017",2017-02-09 16:36:11 +0000,http://www.capitalcube.com/blog/index.php/haemonetics-corp-hae-us-earnings-analysis-q3-2017-by-the-numbers-february-9-2017/,"Haemonetics Corp. :HAE-US: Earnings Analysis: Q3, 2017 By the Numbers : February 9, 2017"
HAE,HAE:US,BBG000C7TF41,Haemonetics (HAE) Beats Q3 Earnings & Revenue Estimates,2017-02-07 17:20:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dU2UfHvmudQ/haemonetics-hae-beats-q3-earnings-revenue-estimates-cm744284,Haemonetics Corporation HAE reported adjusted earnings per share EPS of 43 cents in the third quarter of fiscal 2017 beating the Zacks Consensus Estimate by 7 5 However adjusted EPS declined 10 from the year ago number On a reported basis Haemonetics posted net income of 15 4
HAE,HAE:US,BBG000C7TF41,Haemonetics (HAE) Beats Q3 Earnings & Revenue Estimates,2017-02-07 15:12:03 +0000,http://finance.yahoo.com/news/haemonetics-hae-beats-q3-earnings-151203299.html?.tsrc=rss,"Haemonetics Corporation (HAE) reported adjusted earnings per share (EPS) of 43 cents in the third quarter of fiscal 2017, beating the Zacks Consensus Estimate by 7.5%."
HAE,HAE:US,BBG000C7TF41,Haemonetics (HAE) Beats Q3 Earnings & Revenue Estimates,2017-02-07 15:12:03 +0000,http://finance.yahoo.com/news/haemonetics-hae-beats-q3-earnings-151203299.html,Haemonetics (HAE) Beats Q3 Earnings & Revenue Estimates
HAE,HAE:US,BBG000C7TF41,Haemonetics downgraded by Barrington Research,2017-02-07 14:26:07 +0000,http://finance.yahoo.com/q/ud?s=HAE,Haemonetics downgraded by Barrington Research
HAE,HAE:US,BBG000C7TF41,Edited Transcript of HAE earnings conference call or presentation 6-Feb-17 1:00pm GMT,2017-02-06 23:10:10 +0000,http://finance.yahoo.com/news/edited-transcript-hae-earnings-conference-231010442.html,Edited Transcript of HAE earnings conference call or presentation 6-Feb-17 1:00pm GMT
HAE,HAE:US,BBG000C7TF41,Edited Transcript of HAE earnings conference call or presentation 6-Feb-17 1:00pm GMT,2017-02-06 23:10:10 +0000,http://finance.yahoo.com/news/edited-transcript-hae-earnings-conference-231010442.html?.tsrc=rss,Q3 2017 Haemonetics Corp Earnings Call
HAE,HAE:US,BBG000C7TF41,"Gainers & Losers Of The Day: PULM, AQB, GALE, PETX, KTOV...",2017-02-06 20:46:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0AU-NLkFUkg/gainers--losers-of-the-day-pulm-aqb-gale-petx-ktov-20170206-01406,"Gainers & Losers Of The Day: PULM, AQB, GALE, PETX, KTOV..."
HAE,HAE:US,BBG000C7TF41,Haemonetics Corp Earnings Call scheduled for 8:00 am ET today,2017-02-06 13:00:00 +0000,http://biz.yahoo.com/cc/5/155135.html,Haemonetics Corp Earnings Call scheduled for 8:00 am ET today
HAE,HAE:US,BBG000C7TF41,Q3 2017 Haemonetics Corp Earnings Release - 06:00 am ET,2017-02-06 12:07:03 +0000,http://biz.yahoo.com/research/earncal/20170206.html?t=hae,Q3 2017 Haemonetics Corp Earnings Release - 06:00 am ET
HAE,HAE:US,BBG000C7TF41,Haemonetics tops Street 3Q forecasts,2017-02-06 11:18:23 +0000,http://sg.finance.yahoo.com/news/haemonetics-tops-street-3q-forecasts-111823793.html,Haemonetics tops Street 3Q forecasts
HAE,HAE:US,BBG000C7TF41,Haemonetics tops Street 3Q forecasts,2017-02-06 11:18:23 +0000,http://finance.yahoo.com/news/haemonetics-tops-street-3q-forecasts-111823266.html?.tsrc=rss,"On a per-share basis, the Braintree, Massachusetts-based company said it had profit of 30 cents. Earnings, adjusted for one-time gains and costs, came to 43 cents per share. The results topped Wall Street ..."
HAE,HAE:US,BBG000C7TF41,"6:11 am Haemonetics beats by $0.03, beats on revs; raises FY17 EPS and revs outlook to high end of previous guidance",2017-02-06 11:11:00 +0000,http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#hae,"6:11 am Haemonetics beats by $0.03, beats on revs; raises FY17 EPS and revs outlook to high end of previous guidance"
HAE,HAE:US,BBG000C7TF41,"HAEMONETICS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits",2017-02-06 11:05:44 +0000,http://biz.yahoo.com/e/170206/hae8-k.html,"HAEMONETICS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits"
HAE,HAE:US,BBG000C7TF41,Haemonetics 3rd Quarter Fiscal 2017 Earnings Release Available on Investor Relations Website,2017-02-06 11:00:00 +0000,http://finance.yahoo.com/news/haemonetics-3rd-quarter-fiscal-2017-110000622.html?.tsrc=rss,"BRAINTREE, Mass., Feb. 6, 2017 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) today announced that third quarter and year-to-date fiscal year 2017 financial results are available on its Investor relations ..."
HAE,HAE:US,BBG000C7TF41,Haemonetics 3rd Quarter Fiscal 2017 Earnings Release Available on Investor Relations Website,2017-02-06 11:00:00 +0000,http://finance.yahoo.com/news/haemonetics-3rd-quarter-fiscal-2017-110000622.html,"[PR Newswire] - BRAINTREE, Mass., Feb. 6, 2017 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) today announced that third quarter and year-to-date fiscal year 2017 financial results are available on its Investor relations ..."
HAE,HAE:US,BBG000C7TF41,Haemonetics Posts Q3 Profit; Sees FY Results To Be At High End Of Prior Range,2017-02-06 06:58:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QRhHbDhCPTg/haemonetics-posts-q3-profit-sees-fy-results-to-be-at-high-end-of-prior-range-20170206-00300,Haemonetics Posts Q3 Profit; Sees FY Results To Be At High End Of Prior Range
HAE,HAE:US,BBG000C7TF41,"Pre-Market Earnings Report for February 6, 2017 :  SYY, NWL, TSN, L, CNA, HAS, BWP, MCY, DO, HAE, FGL, AINV",2017-02-05 21:17:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nEjOz8G1Lkk/pre-market-earnings-report-for-february-6-2017-syy-nwl-tsn-l-cna-has-bwp-mcy-do-hae-fgl-ainv-cm743385,The following companies are expected to report earnings prior to market open on 02 06 2017 Visit our Earnings Calendar for a full list of expected earnings releases Sysco Corporation SYY is reporting for the quarter ending December 31 2016 The
HAE,HAE:US,BBG000C7TF41,"Pre-Market Earnings Report for February 6, 2017 :  SYY, NWL, TSN, L, CNA, HAS, BWP, MCY, DO, HAE, FGL, AINV",2017-02-03 21:16:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EOQNb_oOwbM/pre-market-earnings-report-for-february-6-2017-syy-nwl-tsn-l-cna-has-bwp-mcy-do-hae-fgl-ainv-cm743155,The following companies are expected to report earnings prior to market open on 02 06 2017 Visit our Earnings Calendar for a full list of expected earnings releases Sysco Corporation SYY is reporting for the quarter ending December 31 2016 The
HAE,HAE:US,BBG000C7TF41,"ETFs with exposure to Haemonetics Corp. : February 3, 2017",2017-02-03 15:53:22 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-haemonetics-corp-february-3-2017/,"ETFs with exposure to Haemonetics Corp. : February 3, 2017"
HAE,HAE:US,BBG000C7TF41,"ETFs with exposure to Haemonetics Corp. : February 3, 2017",2017-02-03 15:53:22 +0000,http://finance.yahoo.com/r/4c94f75d-2bf7-3603-99e3-36a854117347/etfs-with-exposure-to-haemonetics-corp-february-3-2017?yptr=yahoo&.tsrc=rss,"Categories:   ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Haemonetics Corp. Here are 5 ETFs with the largest exposure to HAE-US. Comparing the performance and risk of Haemonetics Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more    
<b>(Read more...)</b>"
HAE,HAE:US,BBG000C7TF41,"Medical Product Stocks' Earnings on Feb 6: HAE, PAHC & More",2017-02-03 14:35:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yAAbmSW-4t4/medical-product-stocks-earnings-on-feb-6-hae-pahc-more-cm742709,The fourth quarter earnings season so far has successfully demonstrated all signs for a steady improvement over the last seven quarters Finance in particular is doing extremely well and energy entering into the positive zone with regards to earnings growth for the first time in more than
HAE,HAE:US,BBG000C7TF41,"Medical Product Stocks' Earnings on Feb 6: HAE, PAHC & More",2017-02-03 12:42:12 +0000,http://finance.yahoo.com/news/medical-product-stocks-earnings-feb-124212451.html,"Medical Product Stocks' Earnings on Feb 6: HAE, PAHC & More"
HAE,HAE:US,BBG000C7TF41,"Medical Product Stocks' Earnings on Feb 6: HAE, PAHC & More",2017-02-03 12:42:12 +0000,http://finance.yahoo.com/news/medical-product-stocks-earnings-feb-124212451.html?.tsrc=rss,Let's take a look at the major Medical products stocks slated to release their quarterly reports on Feb 6.
HAE,HAE:US,BBG000C7TF41,"Haemonetics Corp. breached its 50 day moving average in a Bullish Manner : HAE-US : February 2, 2017",2017-02-02 12:25:22 +0000,http://finance.yahoo.com/r/08aa1d5c-d46d-32fc-a586-ed8a54818f4c/haemonetics-corp-breached-its-50-day-moving-average-in-a-bullish-manner-hae-us-february-2-2017?yptr=yahoo&.tsrc=rss,"Categories:   ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Haemonetics Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average ... Read more    
<b>(Read more...)</b>"
HAE,HAE:US,BBG000C7TF41,"Haemonetics Corp. breached its 50 day moving average in a Bullish Manner : HAE-US : February 2, 2017",2017-02-02 12:25:22 +0000,http://www.capitalcube.com/blog/index.php/haemonetics-corp-breached-its-50-day-moving-average-in-a-bullish-manner-hae-us-february-2-2017/,"Haemonetics Corp. breached its 50 day moving average in a Bullish Manner : HAE-US : February 2, 2017"
HAE,HAE:US,BBG000C7TF41,What Will Valeant Pharmaceuticals Sell Off Next?,2017-01-20 21:37:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GX6NLRB1Th4/what-will-valeant-pharmaceuticals-sell-off-next-cm736211,Believe it or not Valeant Pharmaceuticals NYSE VRX stock is actually outperforming the S amp P 500 160 so far in 2017 That s a far cry from the shellacking Valeant took last year losing 85 of its value Selling some of its assets is helping the drugmaker to take the
HAE,HAE:US,BBG000C7TF41,"Haemonetics Corp. – Value Analysis (NYSE:HAE) : January 19, 2017",2017-01-19 15:43:20 +0000,http://finance.yahoo.com/r/34d76f51-b4ef-3ae0-9c4a-91e25ce13205/haemonetics-corp-value-analysis-nysehae-january-19-2017?yptr=yahoo&.tsrc=rss,"Categories:   Fundamental Analysis Yahoo Finance Click here to see latest analysis Capitalcube gives Haemonetics Corp. a score of 25. Our analysis is based on comparing Haemonetics Corp. with the following peers – Thermo Fisher Scientific Inc., Stryker Corporation, Becton, Dickinson and Company, Cerus Corporation, C. R. Bard, Inc., Baxter International Inc., PerkinElmer, Inc., Cytori Therapeutics, Inc., Medtronic plc and HemaCare ... Read more    
<b>(Read more...)</b>"
HAE,HAE:US,BBG000C7TF41,"Haemonetics Corp. – Value Analysis (NYSE:HAE) : January 19, 2017",2017-01-19 15:43:20 +0000,http://www.capitalcube.com/blog/index.php/haemonetics-corp-value-analysis-nysehae-january-19-2017/,"Haemonetics Corp. – Value Analysis (NYSE:HAE) : January 19, 2017"
HAE,HAE:US,BBG000C7TF41,"Haemonetics Corp. breached its 50 day moving average in a Bearish Manner : HAE-US : January 18, 2017",2017-01-18 14:50:28 +0000,http://www.capitalcube.com/blog/index.php/haemonetics-corp-breached-its-50-day-moving-average-in-a-bearish-manner-hae-us-january-18-2017/,"Haemonetics Corp. breached its 50 day moving average in a Bearish Manner : HAE-US : January 18, 2017"
HAE,HAE:US,BBG000C7TF41,"Haemonetics Corp. breached its 50 day moving average in a Bearish Manner : HAE-US : January 18, 2017",2017-01-18 14:50:28 +0000,http://finance.yahoo.com/r/be47d574-1cd4-34c8-ba2d-18ce86784938/haemonetics-corp-breached-its-50-day-moving-average-in-a-bearish-manner-hae-us-january-18-2017?yptr=yahoo&.tsrc=rss,"Categories:   ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Haemonetics Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average ... Read more    
<b>(Read more...)</b>"
HAE,HAE:US,BBG000C7TF41,"Haemonetics Sets Date for 3rd Quarter Fiscal 2017 Earnings Release: February 6, 2017",2017-01-17 21:01:00 +0000,http://finance.yahoo.com/news/haemonetics-sets-date-3rd-quarter-210100746.html?.tsrc=rss,"BRAINTREE, Mass., Jan. 17, 2017 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) today announced that the Company will publish fiscal year 2017 third quarter financial results at 6:00am Eastern Time ..."
HAE,HAE:US,BBG000C7TF41,"Haemonetics Sets Date for 3rd Quarter Fiscal 2017 Earnings Release: February 6, 2017",2017-01-17 21:01:00 +0000,http://finance.yahoo.com/news/haemonetics-sets-date-3rd-quarter-210100746.html,"[PR Newswire] - BRAINTREE, Mass., Jan. 17, 2017 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) today announced that the Company will publish fiscal year 2017 third quarter financial results at 6:00am Eastern Time ..."
HAE,HAE:US,BBG000C7TF41,"Walgreens Boots (WBA) Beats Q1 Earnings, Trims EPS View",2017-01-05 17:38:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QCaJ449FYY8/walgreens-boots-wba-beats-q1-earnings-trims-eps-view-cm729863,Walgreens Boots Alliance Inc WBA reported adjusted earnings per share EPS of 1 10 in first quarter fiscal 2017 up 6 8 from the year ago quarter Adjusted EPS also beat the Zacks Consensus Estimate slightly by 0 9 On a reported basis net earnings came in at 1 05 billion a decrease
HAE,HAE:US,BBG000C7TF41,"Walgreens Boots (WBA) Beats Q1 Earnings, Trims EPS View",2017-01-05 15:23:03 +0000,http://finance.yahoo.com/news/walgreens-boots-wba-beats-q1-152303381.html?.tsrc=rss,"Walgreens Boots Alliance, Inc. (WBA) reported adjusted earnings per share (EPS) of $1.10 in first-quarter fiscal 2017, up 6.8% from the year-ago quarter."
HAE,HAE:US,BBG000C7TF41,"Walgreens Boots (WBA) Beats Q1 Earnings, Trims EPS View",2017-01-05 15:23:03 +0000,http://finance.yahoo.com/news/walgreens-boots-wba-beats-q1-152303381.html,"Walgreens Boots (WBA) Beats Q1 Earnings, Trims EPS View"
HAE,HAE:US,BBG000C7TF41,ResMed Achieves Key Milestone in Sleep-Disordered Breathing,2017-01-05 13:39:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/udb_9aH5PuM/resmed-achieves-key-milestone-in-sleep-disordered-breathing-cm729644,While remote patient monitoring market is growing fast to become a 30 billion industry by 2020 tech analyst firm Berg Insight s data renowned sleep disordered breathing SDB company ResMed Inc RMD recently achieved a significant milestone in this respect After one billion nights of
HAE,HAE:US,BBG000C7TF41,"Bruker Buys SCiLS, Expands in Mass Spectrometry Imaging",2017-01-05 13:39:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MzphpatRgoI/bruker-buys-scils-expands-in-mass-spectrometry-imaging-cm729643,Bruker Corporation BRKR a major player in the field of life science materials research systems and associated products has recently announced the acquisition of Bremen Germany based software solutions developer SCiLS GmbH Financial terms of the deal have been kept under wraps We
HAE,HAE:US,BBG000C7TF41,"Bruker Buys InVivo Biotech, Boosts MALDI Biotyper Suite",2017-01-05 13:39:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fQuR56WYCzY/bruker-buys-invivo-biotech-boosts-maldi-biotyper-suite-cm729686,Bruker Corporation BRKR a renowned name in the field of proprietary life science and materials research systems recently announced the buyout of InVivo Biotech Services GmbH This Hennigsdorf Germany based company is a molecular biology contract manufacturing organization CMO and a
HAE,HAE:US,BBG000C7TF41,"Bruker Buys InVivo Biotech, Boosts MALDI Biotyper Suite",2017-01-05 12:07:12 +0000,http://finance.yahoo.com/news/bruker-buys-invivo-biotech-boosts-120712123.html?.tsrc=rss,"Bruker Corporation (BRKR) recently announced the buyout of Hennigsdorf, Germany-based InVivo Biotech Services GmbH."
HAE,HAE:US,BBG000C7TF41,"Bruker Buys InVivo Biotech, Boosts MALDI Biotyper Suite",2017-01-05 12:07:12 +0000,http://finance.yahoo.com/news/bruker-buys-invivo-biotech-boosts-120712123.html,"Bruker Buys InVivo Biotech, Boosts MALDI Biotyper Suite"
HAE,HAE:US,BBG000C7TF41,"Bruker Buys SCiLS, Expands in Mass Spectrometry Imaging",2017-01-05 11:56:11 +0000,http://finance.yahoo.com/news/bruker-buys-scils-expands-mass-115611813.html?.tsrc=rss,"Bruker Corporation (BRKR) recently announced the acquisition of Bremen, Germany-based software solutions developer, SCiLS GmbH."
HAE,HAE:US,BBG000C7TF41,"Bruker Buys SCiLS, Expands in Mass Spectrometry Imaging",2017-01-05 11:56:11 +0000,http://finance.yahoo.com/news/bruker-buys-scils-expands-mass-115611813.html,"Bruker Buys SCiLS, Expands in Mass Spectrometry Imaging"
HAE,HAE:US,BBG000C7TF41,ResMed Achieves Key Milestone in Sleep-Disordered Breathing,2017-01-05 11:52:11 +0000,http://finance.yahoo.com/news/resmed-achieves-key-milestone-sleep-115211811.html,"[Zacks] - After one billion nights of sleep data was downloaded using ResMed's remote patient monitoring platform AirView, the company reached a landmark in the field of sleep research and treatment of sleep apnea."
HAE,HAE:US,BBG000C7TF41,ResMed Achieves Key Milestone in Sleep-Disordered Breathing,2017-01-05 11:52:11 +0000,http://finance.yahoo.com/news/resmed-achieves-key-milestone-sleep-115211811.html?.tsrc=rss,"After one billion nights of sleep data was downloaded using ResMed's remote patient monitoring platform AirView, the company reached a landmark in the field of sleep research and treatment of sleep apnea."
HAE,HAE:US,BBG000C7TF41,Hologic (HOLX) Receives PMA for Aptima HIV-1 Quant Assay,2017-01-04 15:41:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cwHC3-qtyfg/hologic-holx-receives-pma-for-aptima-hiv-1-quant-assay-cm729204,Diagnostic instruments major Hologic Inc HOLX recently announced the receipt of the FDA s Premarket Approval PMA for its Aptima HIV 1 Quant assay This viral load monitoring assay falls under the company s Diagnostic Solutions division It is a nucleic acid amplification test for
HAE,HAE:US,BBG000C7TF41,Hologic (HOLX) Receives PMA for Aptima HIV-1 Quant Assay,2017-01-04 13:39:01 +0000,http://finance.yahoo.com/news/hologic-holx-receives-pma-aptima-133901772.html,Hologic (HOLX) Receives PMA for Aptima HIV-1 Quant Assay
HAE,HAE:US,BBG000C7TF41,Hologic (HOLX) Receives PMA for Aptima HIV-1 Quant Assay,2017-01-04 13:39:01 +0000,http://finance.yahoo.com/news/hologic-holx-receives-pma-aptima-133901772.html?.tsrc=rss,"Hologic, Inc. (HOLX) recently announced the receipt of the FDAs Premarket Approval (PMA) for its Aptima HIV-1 Quant assay."
HAE,HAE:US,BBG000C7TF41,Illumina Fettered With Losses: Can It Bounce Back in 2017?,2017-01-03 15:02:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UKLFDPDBDxg/illumina-fettered-with-losses-can-it-bounce-back-in-2017-cm728496,Investors are constantly on the lookout for newer strategies to rake in market beating returns One easy way to gauge where the stock is headed in 2017 is to go through its performance in relation to the peer group or industry in the year gone by However the below par performance by the stocks
HAE,HAE:US,BBG000C7TF41,Haemonetics to Present at 35th Annual J.P. Morgan Health Care Conference,2017-01-03 15:00:00 +0000,http://finance.yahoo.com/news/haemonetics-present-35th-annual-j-150000190.html,"[PR Newswire] - BRAINTREE, Mass., Jan. 3, 2017 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the 35 th Annual J.P. Morgan Healthcare Conference in San ..."
HAE,HAE:US,BBG000C7TF41,Masimo to Launch Advanced Monitoring Technologies in India,2017-01-03 13:58:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/itSerpgeioA/masimo-to-launch-advanced-monitoring-technologies-in-india-cm728510,Irvine CA based Masimo MASI announced that it will launch Advanced Monitoring Technologies in the Indian market The company has decided to introduce its proprietary Rad 97 Pulse CO Oximeter and Next Generation SedLine Brain Function Monitoring in India Masimo rallied 71 98 over the
HAE,HAE:US,BBG000C7TF41,Illumina Fettered With Losses: Can It Bounce Back in 2017?,2017-01-03 13:02:01 +0000,http://finance.yahoo.com/news/illumina-fettered-losses-bounce-back-130201572.html,Illumina Fettered With Losses: Can It Bounce Back in 2017?
HAE,HAE:US,BBG000C7TF41,Masimo to Launch Advanced Monitoring Technologies in India,2017-01-03 12:31:12 +0000,http://finance.yahoo.com/news/masimo-launch-advanced-monitoring-technologies-123112960.html,Masimo to Launch Advanced Monitoring Technologies in India
HAE,HAE:US,BBG000C7TF41,OPKO Health (OPK) Reports Failure in hGH-CTP Phase 3,2017-01-02 15:58:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uN9EeRgX0_g/opko-health-opk-reports-failure-in-hgh-ctp-phase-3-cm728370,Diversified healthcare company OPKO Health Inc OPK announced failure in its data analysis of the Phase 3 Clinical Study of hGH CTP in Growth Hormone Deficient Adults The study of hGH CTP in adults with growth hormone deficiency demonstrated no statistical difference versus placebo In
HAE,HAE:US,BBG000C7TF41,Abaxis (ABAX) Veterinary Prospects Bright: Should You Hold?,2017-01-02 14:58:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XPekTfN9fRg/abaxis-abax-veterinary-prospects-bright-should-you-hold-cm728334,On Jan 2 2017 Abaxis Inc ABAX a leading manufacturer of portable medical and veterinary blood analysis systems was upgraded to a Zacks Rank 3 Hold Why the Upgrade We believe the upgrade was primarily driven by Abaxis rising share price in the last six months The
HAE,HAE:US,BBG000C7TF41,OPKO Health (OPK) Reports Failure in hGH-CTP Phase 3,2017-01-02 13:23:01 +0000,http://finance.yahoo.com/news/opko-health-opk-reports-failure-132301719.html,OPKO Health (OPK) Reports Failure in hGH-CTP Phase 3
HAE,HAE:US,BBG000C7TF41,Abaxis (ABAX) Veterinary Prospects Bright: Should You Hold?,2017-01-02 12:53:12 +0000,http://finance.yahoo.com/news/abaxis-abax-veterinary-prospects-bright-125312734.html,Abaxis (ABAX) Veterinary Prospects Bright: Should You Hold?
HAE,HAE:US,BBG000C7TF41,Is Baxter Poised to Counter Low Cyclophosphamide Sales?,2016-12-30 17:01:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TSwRSMqgIw4/is-baxter-poised-to-counter-low-cyclophosphamide-sales-cm727964,On Dec 30 we issued an updated research report on Deerfield IL based Baxter International Inc BAX a global medical technology company and leading provider of renal and hospital products Over the past six months Baxter outperformed the broader market in terms of price
HAE,HAE:US,BBG000C7TF41,CryoLife (CRY) Now a Strong Buy on Solid Estimate Revisions,2016-12-30 16:02:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4A9BN9Nmt7U/cryolife-cry-now-a-strong-buy-on-solid-estimate-revisions-cm727856,On Dec 27 CryoLife Inc CRY was upgraded to a Zacks Rank 1 Strong Buy Headquartered in Kennesaw GA the company manufactures and distributes medical devices worldwide Why the Upgrade The stock represents a stellar year to date gain of almost 79 5 way better than the
HAE,HAE:US,BBG000C7TF41,NuVasive (NUVA) Wins MHLW Approval for XLIF Device Suite,2016-12-30 15:01:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bOWPcIvD2U0/nuvasive-nuva-wins-mhlw-approval-for-xlif-device-suite-cm727905,Leading medical device company NuVasive Inc NUVA recently announced the receipt of approval from the Japanese Ministry of Health Labour and Welfare MHLW for instruments used in the eXtreme Lateral Interbody Fusion XLIF procedure These devices fall under the company s global
HAE,HAE:US,BBG000C7TF41,Alere (ALR) Appeals to Reinstate Medicare Billing Privilege,2016-12-30 15:01:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ivSHV4f7EaA/alere-alr-appeals-to-reinstate-medicare-billing-privilege-cm727903,Waltham MA based Alere Inc ALR a leading player in rapid diagnostic tests announced that it has recently appealed to the Administrative Law Judge at the Centers for Medicare amp Medicaid Services for reinstatement of Medicare billing privilege For the last six months the
HAE,HAE:US,BBG000C7TF41,Is Baxter Poised to Counter Low Cyclophosphamide Sales?,2016-12-30 14:34:02 +0000,http://finance.yahoo.com/news/baxter-poised-counter-low-cyclophosphamide-143402008.html,Is Baxter Poised to Counter Low Cyclophosphamide Sales?
HAE,HAE:US,BBG000C7TF41,CryoLife (CRY) Now a Strong Buy on Solid Estimate Revisions,2016-12-30 13:54:01 +0000,http://finance.yahoo.com/news/cryolife-cry-now-strong-buy-135401370.html,CryoLife (CRY) Now a Strong Buy on Solid Estimate Revisions
HAE,HAE:US,BBG000C7TF41,Alere (ALR) Appeals to Reinstate Medicare Billing Privilege,2016-12-30 13:30:01 +0000,http://finance.yahoo.com/news/alere-alr-appeals-reinstate-medicare-133001608.html,Alere (ALR) Appeals to Reinstate Medicare Billing Privilege
HAE,HAE:US,BBG000C7TF41,NuVasive (NUVA) Wins MHLW Approval for XLIF Device Suite,2016-12-30 13:28:01 +0000,http://finance.yahoo.com/news/nuvasive-nuva-wins-mhlw-approval-132801422.html,NuVasive (NUVA) Wins MHLW Approval for XLIF Device Suite
HAE,HAE:US,BBG000C7TF41,Nutrisystem Declares Multi-Brand Marketing Approach for '17,2016-12-29 13:59:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8BQTks0y4JQ/nutrisystem-declares-multi-brand-marketing-approach-for-17-cm727273,Weight management products and service provider Nutrisystem Inc NTRI announced that it will focus on a multi brand marketing approach with two new distinct programs Nutrisystem Lean13 and the South Beach Diet in 2017 A glimpse at the stock price movement reveals a solid trend
HAE,HAE:US,BBG000C7TF41,"ResMed: SDB Business Faces Risks, Reimbursement a Drag",2016-12-29 13:59:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zIwnELSRGsg/resmed-sdb-business-faces-risks-reimbursement-a-drag-cm727307,On Dec 27 we issued an updated research report on San Diego CA based ResMed Inc RMD The company is a global manufacturer and distributor of generators masks and related accessories for the treatment of sleep disordered breathing SDB and other respiratory disorders At present
HAE,HAE:US,BBG000C7TF41,"LabCorp: Covance Drug Prospects Bright, Competition Rife",2016-12-29 13:59:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QN9HyXY7-uM/labcorp-covance-drug-prospects-bright-competition-rife-cm727305,On Dec 28 we issued an updated research report on Burlington NC based Laboratory Corporation of America Holdings LH or LabCorp The company is a major player in the healthcare diagnostics space providing comprehensive clinical laboratory services and end to end drug development support
HAE,HAE:US,BBG000C7TF41,"LabCorp: Covance Drug Prospects Bright, Competition Rife",2016-12-29 13:03:01 +0000,http://finance.yahoo.com/news/labcorp-covance-drug-prospects-bright-130301984.html,"LabCorp: Covance Drug Prospects Bright, Competition Rife"
HAE,HAE:US,BBG000C7TF41,"ResMed: SDB Business Faces Risks, Reimbursement a Drag",2016-12-29 13:02:01 +0000,http://finance.yahoo.com/news/resmed-sdb-business-faces-risks-130201927.html,"[Zacks] - On Dec 27, we issued an updated research report on San Diego, CA-based ResMed, Inc. (RMD)."
HAE,HAE:US,BBG000C7TF41,Nutrisystem Declares Multi-Brand Marketing Approach for '17,2016-12-29 12:19:12 +0000,http://finance.yahoo.com/news/nutrisystem-declares-multi-brand-marketing-121912140.html,Nutrisystem Declares Multi-Brand Marketing Approach for '17
HAE,HAE:US,BBG000C7TF41,"Cardiovascular Systems (CSII): Q1 Solid, Net Losses Linger",2016-12-28 15:02:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SSCJgU4OgYQ/cardiovascular-systems-csii-q1-solid-net-losses-linger-cm726789,On Dec 27 we issued an updated research report on St Paul MN based Cardiovascular Systems Inc CSII The company is a medical device manufacturer that develops and commercializes innovative solutions to treat patients suffering from peripheral and coronary arterial diseases including
HAE,HAE:US,BBG000C7TF41,Myriad Genetics' Unit Releases Favorable Data on Vectra DA,2016-12-28 15:01:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rfFDUov-4zY/myriad-genetics-unit-releases-favorable-data-on-vectra-da-cm726776,Myriad Genetics Inc s MYGN subsidiary Crescendo Bioscience continues to make development with its Vectra DA assay After last week s announcement of its contract with United Rheumatology on this assay it has once again come up with favorable data on the use of Vectra DA to predict
HAE,HAE:US,BBG000C7TF41,Myriad Genetics' Unit Releases Favorable Data on Vectra DA,2016-12-28 13:02:01 +0000,http://finance.yahoo.com/news/myriad-genetics-unit-releases-favorable-130201382.html,Myriad Genetics' Unit Releases Favorable Data on Vectra DA
HAE,HAE:US,BBG000C7TF41,"Cardiovascular Systems (CSII): Q1 Solid, Net Losses Linger",2016-12-28 12:36:12 +0000,http://finance.yahoo.com/news/cardiovascular-systems-csii-q1-solid-123612373.html,"Cardiovascular Systems (CSII): Q1 Solid, Net Losses Linger"
HAE,HAE:US,BBG000C7TF41,The Most Expensive Drugs of 2016,2016-12-18 17:57:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_-tI5zo30LU/the-most-expensive-drugs-of-2016-cm722995,Prescription drug prices have gotten out of control for many Americans and many insurers Some drugs cost as much as premium sports cars Here are the five most expensive prescription drugs in 2016 as compiled by prescription drug comparison website GoodRx and which companies
HAE,HAE:US,BBG000C7TF41,"Haemonetics' Plasma Group Impresses, Blood Center a Drag",2016-12-13 16:01:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vhQUtFCNV1I/haemonetics-plasma-group-impresses-blood-center-a-drag-cm720681,On Dec 12 we issued an updated research report on Braintree MA based Haemonetics Corporation HAE The company offers blood management solutions to customers including blood and plasma collectors hospitals and health care providers globally Heamonetics has been performing well in
HAE,HAE:US,BBG000C7TF41,"Haemonetics' Plasma Group Impresses, Blood Center a Drag",2016-12-13 13:41:01 +0000,http://finance.yahoo.com/news/haemonetics-plasma-group-impresses-blood-134101283.html,"Haemonetics' Plasma Group Impresses, Blood Center a Drag"
HAE,HAE:US,BBG000C7TF41,Haemonetics Introduces Upgraded NextGen DMS 4 Software,2016-12-09 16:00:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TDPKYN3P7DE/haemonetics-introduces-upgraded-nextgen-dms-4-software-cm719202,Haemonetics Corporation HAE a major global provider of blood and plasma supplies and services recently unveiled a major upgrade to NextGen DMS Donor Management System The NextGen DMS is an advanced set of software that has been developed to enhance plasma collection center
HAE,HAE:US,BBG000C7TF41,Haemonetics Introduces Upgraded NextGen DMS 4 Software,2016-12-09 14:13:02 +0000,http://finance.yahoo.com/news/haemonetics-introduces-upgraded-nextgen-dms-141302975.html,Haemonetics Introduces Upgraded NextGen DMS 4 Software
HAE,HAE:US,BBG000C7TF41,Should You Avoid Haemonetics Corporation (HAE)?,2016-12-09 14:02:29 +0000,http://www.insidermonkey.com/blog/should-you-avoid-haemonetics-corporation-hae-501683/,Should You Avoid Haemonetics Corporation (HAE)?
HAE,HAE:US,BBG000C7TF41,Haemonetics Announces the Release of NextGen DMS 4,2016-12-08 13:00:00 +0000,http://finance.yahoo.com/news/haemonetics-announces-release-nextgen-dms-130000988.html,"[PR Newswire] - BRAINTREE, Mass., Dec. 8, 2016 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) has released an extensive upgrade to NextGen DMS (Donor Management System), an innovative software suite designed to help ..."
HAE,HAE:US,BBG000C7TF41,Haemonetics (HAE) Hits a 52-Week High on Solid Prospects,2016-11-28 14:33:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SH5J_mb8E6s/haemonetics-hae-hits-a-52-week-high-on-solid-prospects-cm714367,Share price of Braitree MA based Haemonetics Corporation HAE reached a new 52 week high of 39 94 on Nov 25 finally closing a bit lower at 39 89 The company gained 23 7 year to date much better than the S amp P 500 s 8 3 over the same time frame It has added roughly 23 3 over the
HAE,HAE:US,BBG000C7TF41,Haemonetics (HAE) Hits a 52-Week High on Solid Prospects,2016-11-28 12:38:12 +0000,http://finance.yahoo.com/news/haemonetics-hae-hits-52-week-123812053.html,Haemonetics (HAE) Hits a 52-Week High on Solid Prospects
HAE,HAE:US,BBG000C7TF41,Haemonetics: Medical Center of Plano Picks BloodTrack,2016-11-22 15:22:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TDfOU25CZu8/haemonetics-medical-center-of-plano-picks-bloodtrack-cm712579,Haemonetics Corporation HAE a global provider of healthcare technology and products recently announced the installation of its BloodTrack Emerge software at The Medical Center of Plano The software has been deployed for blood management at the time of emergency Several
HAE,HAE:US,BBG000C7TF41,Haemonetics: Medical Center of Plano Picks BloodTrack,2016-11-22 13:19:01 +0000,http://finance.yahoo.com/news/haemonetics-medical-center-plano-picks-131901602.html,Haemonetics: Medical Center of Plano Picks BloodTrack
HAE,HAE:US,BBG000C7TF41,The Medical Center of Plano Texas Selects Haemonetics® BloodTrack® Technology,2016-11-18 13:20:04 +0000,http://www.publicnow.com/view/AA9F4D7F0E3DC1036542FF904D96BE08615EE03F,"[at noodls] - BRAINTREE, Mass., Nov. 18, 2016 /PRNewswire/ -- Haemonetics, a healthcare technology provider dedicated to delivering innovative products and solutions to healthcare organizations around the world, today ..."
HAE,HAE:US,BBG000C7TF41,"HAEMONETICS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits",2016-11-17 21:03:29 +0000,http://biz.yahoo.com/e/161117/hae8-k.html,"HAEMONETICS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits"
HAE,HAE:US,BBG000C7TF41,"HAEMONETICS CORP Files SEC form 8-K, Change in Directors or Principal Officers",2016-11-14 21:10:33 +0000,http://biz.yahoo.com/e/161114/hae8-k.html,"HAEMONETICS CORP Files SEC form 8-K, Change in Directors or Principal Officers"
HAE,HAE:US,BBG000C7TF41,"Haemonetics Corp. :HAE-US: Earnings Analysis: Q2, 2017 By the Numbers : November 11, 2016",2016-11-11 15:47:31 +0000,http://www.capitalcube.com/blog/index.php/haemonetics-corp-hae-us-earnings-analysis-q2-2017-by-the-numbers-november-11-2016/,"Haemonetics Corp. :HAE-US: Earnings Analysis: Q2, 2017 By the Numbers : November 11, 2016"
HAE,HAE:US,BBG000C7TF41,"ETF’s with exposure to Haemonetics Corp. : November 9, 2016",2016-11-09 17:50:34 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-haemonetics-corp-november-9-2016/,"ETF’s with exposure to Haemonetics Corp. : November 9, 2016"
HAE,HAE:US,BBG000C7TF41,Haemonetics (HAE) Q2 Earnings & Revenues Beat Estimates,2016-11-08 20:42:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0mmK27W6su4/haemonetics-hae-q2-earnings-revenues-beat-estimates-cm705559,Haemonetics Corporation HAE reported adjusted earnings per share EPS of 46 cents in the second quarter of fiscal 2017 beating the Zacks Consensus Estimate by 31 4 Moreover adjusted EPS rose 4 5 from the year ago number The company recorded expenses in relation to the
HAE,HAE:US,BBG000C7TF41,Haemonetics (HAE) Q2 Earnings & Revenues Beat Estimates,2016-11-08 14:16:02 +0000,http://finance.yahoo.com/news/haemonetics-hae-q2-earnings-revenues-141602846.html,Haemonetics (HAE) Q2 Earnings & Revenues Beat Estimates
HAE,HAE:US,BBG000C7TF41,"Haemonetics Corp. breached its 50 day moving average in a Bullish Manner : HAE-US : November 8, 2016",2016-11-08 12:56:38 +0000,http://www.capitalcube.com/blog/index.php/haemonetics-corp-breached-its-50-day-moving-average-in-a-bullish-manner-hae-us-november-8-2016/,"Haemonetics Corp. breached its 50 day moving average in a Bullish Manner : HAE-US : November 8, 2016"
HAE,HAE:US,BBG000C7TF41,Edited Transcript of HAE earnings conference call or presentation 7-Nov-16 1:00pm GMT,2016-11-07 19:39:11 +0000,http://finance.yahoo.com/news/edited-transcript-hae-earnings-conference-193911108.html,Edited Transcript of HAE earnings conference call or presentation 7-Nov-16 1:00pm GMT
HAE,HAE:US,BBG000C7TF41,Haemonetics Corp Earnings Call scheduled for 8:00 am ET today,2016-11-07 13:00:00 +0000,http://biz.yahoo.com/cc/3/154223.html,Haemonetics Corp Earnings Call scheduled for 8:00 am ET today
HAE,HAE:US,BBG000C7TF41,Q2 2017 Haemonetics Corp Earnings Release - 06:00 am ET,2016-11-07 12:07:04 +0000,http://biz.yahoo.com/research/earncal/20161107.html?t=hae,Q2 2017 Haemonetics Corp Earnings Release - 06:00 am ET
HAE,HAE:US,BBG000C7TF41,"HAEMONETICS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits",2016-11-07 11:19:56 +0000,http://biz.yahoo.com/e/161107/hae8-k.html,"HAEMONETICS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits"
HAE,HAE:US,BBG000C7TF41,Haemonetics tops Street 2Q forecasts,2016-11-07 11:16:33 +0000,http://sg.finance.yahoo.com/news/haemonetics-tops-street-2q-forecasts-111633671.html,Haemonetics tops Street 2Q forecasts
HAE,HAE:US,BBG000C7TF41,Haemonetics 2nd Quarter Fiscal 2017 Earnings Release Available on Investor Relations Website,2016-11-07 11:14:08 +0000,http://www.publicnow.com/view/1E80416A4646672A8ACAAFEE2CF9811211C52E58,"[at noodls] - BRAINTREE, Mass., Nov. 7, 2016 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) today announced that second quarter and first half fiscal year 2017 financial results are available on its Investor relations ..."
HAE,HAE:US,BBG000C7TF41,Haemonetics Q2 Profit Tops Estimates; Reaffirms FY17 Guidance - Quick Facts,2016-11-07 06:33:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/H5F5gw-yLqM/haemonetics-q2-profit-tops-estimates-reaffirms-fy17-guidance--quick-facts-20161107-00203,Haemonetics Q2 Profit Tops Estimates; Reaffirms FY17 Guidance - Quick Facts
HAE,HAE:US,BBG000C7TF41,"Medical Product Stocks Nov 7 Earnings Lineup: ALGN NVRO, HAE",2016-11-04 13:19:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3Xm-fsY3ubI/medical-product-stocks-nov-7-earnings-lineup-algn-nvro-hae-cm703888,With Q3 earnings reports already out from more than 72 8 of the S amp P 500 members 364 companies our latest Earnings Outlook has exhibited an improving trend so far Proceeding to the last lap of the earnings reporting cycle we are further assured about this quarter being the first
HAE,HAE:US,BBG000C7TF41,"Medical Product Stocks Nov 7 Earnings Lineup: ALGN NVRO, HAE",2016-11-04 10:57:10 +0000,http://finance.yahoo.com/news/medical-product-stocks-nov-7-105710465.html,"Medical Product Stocks Nov 7 Earnings Lineup: ALGN NVRO, HAE"
HAE,HAE:US,BBG000C7TF41,"HAEMONETICS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits",2016-10-27 21:12:12 +0000,http://biz.yahoo.com/e/161027/hae8-k.html,"HAEMONETICS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits"
HAE,HAE:US,BBG000C7TF41,Catherine M. Burzik Joins Haemonetics Board of Directors,2016-10-27 21:08:04 +0000,http://www.publicnow.com/view/C7F4CCD3080151A71A225AA06E3B822ED607F049,"[at noodls] - BRAINTREE, Mass., Oct. 27, 2016 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced the election of Catherine M. Burzik, a highly respected and accomplished senior executive in the healthcare ..."
HAE,HAE:US,BBG000C7TF41,HAE Crosses Above Average Analyst Target,2016-10-20 14:48:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sRrmmLeamlU/hae-crosses-above-average-analyst-target-cm695813,In recent trading shares of Haemonetics Corp Symbol HAE have crossed above the average analyst 12 month target price of 34 57 changing hands for 34 60 share When a stock reaches the target an analyst has set the analyst logically has two ways to react downgrade on valuation
HAE,HAE:US,BBG000C7TF41,"ETF’s with exposure to Haemonetics Corp. : October 19, 2016",2016-10-19 16:14:16 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-haemonetics-corp-october-19-2016/,"ETF’s with exposure to Haemonetics Corp. : October 19, 2016"
HAE,HAE:US,BBG000C7TF41,Haemonetics Enters Oversold Territory (HAE),2016-10-14 21:40:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QcScEuEctLY/haemonetics-enters-oversold-territory-hae-cm693681,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
HAE,HAE:US,BBG000C7TF41,"Haemonetics Sets Date for 2nd Quarter Fiscal 2017 Earnings Release: November 7, 2016",2016-10-13 21:20:05 +0000,http://www.publicnow.com/view/B96CD093B2A9008D8C64A9981DC033F7389EB45B,"[at noodls] - BRAINTREE, Mass., Oct. 13, 2016 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) today announced that the Company will publish fiscal year 2017 second quarter financial results at 6:00am Eastern Time ..."
HAE,HAE:US,BBG000C7TF41,"Haemonetics Corp. breached its 50 day moving average in a Bearish Manner : HAE-US : October 13, 2016",2016-10-13 12:27:17 +0000,http://www.capitalcube.com/blog/index.php/haemonetics-corp-breached-its-50-day-moving-average-in-a-bearish-manner-hae-us-october-13-2016/,"Haemonetics Corp. breached its 50 day moving average in a Bearish Manner : HAE-US : October 13, 2016"
HAE,HAE:US,BBG000C7TF41,"ETF’s with exposure to Haemonetics Corp. : October 4, 2016",2016-10-04 13:57:06 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-haemonetics-corp-october-4-2016/,"ETF’s with exposure to Haemonetics Corp. : October 4, 2016"
HAE,HAE:US,BBG000C7TF41,"ETF’s with exposure to Haemonetics Corp. : September 19, 2016",2016-09-19 14:12:45 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-haemonetics-corp-september-19-2016/,"ETF’s with exposure to Haemonetics Corp. : September 19, 2016"
HAE,HAE:US,BBG000C7TF41,Haemonetics to Present at The Baird 2016 Global Healthcare Conference,2016-09-17 09:18:05 +0000,http://www.publicnow.com/view/D91D6BFD43ED486E44826BDD102E25064A2A1A19,"[at noodls] - BRAINTREE, Mass., Aug. 29, 2016 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that Gerry Gould, Vice President - Investor Relations, will present at The Baird 2016 Global Healthcare Conference ..."
HAE,HAE:US,BBG000C7TF41,"HAEMONETICS CORP Files SEC form 8-K, Change in Directors or Principal Officers",2016-09-15 20:04:09 +0000,http://biz.yahoo.com/e/160915/hae8-k.html,"HAEMONETICS CORP Files SEC form 8-K, Change in Directors or Principal Officers"
HAE,HAE:US,BBG000C7TF41,Haemonetics To Present At Morgan Stanley's Conference; Webcast At 1:40 PM ET,2016-09-12 12:44:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hZ6kC2T3w2s/haemonetics-to-present-at-morgan-stanleys-conference-webcast-at-140-pm-et-20160912-01312,Haemonetics To Present At Morgan Stanley's Conference; Webcast At 1:40 PM ET
HAE,HAE:US,BBG000C7TF41,Haemonetics To Present At Morgan Stanley's Conference; Webcast At 1:40 PM ET,2016-09-12 12:44:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/C3bAL72j9ks/haemonetics-to-present-at-morgan-stanleys-conference-webcast-at-140-pm-et-20160912-00828,Haemonetics To Present At Morgan Stanley's Conference; Webcast At 1:40 PM ET
HAE,HAE:US,BBG000C7TF41,Haemonetics to Present at Morgan Stanley's Global Healthcare Conference,2016-08-31 20:01:00 +0000,http://finance.yahoo.com/news/haemonetics-present-morgan-stanleys-global-200100780.html,"[PR Newswire] - BRAINTREE, Mass., Aug. 31, 2016 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at Morgan Stanley's Global Healthcare Conference in New York ..."
HAE,HAE:US,BBG000C7TF41,Haemonetics to Present at The Baird 2016 Global Healthcare Conference,2016-08-29 20:33:05 +0000,http://www.publicnow.com/view/21977565C905A6EE0CA83BC69C2EC8E240F9982E,"[at noodls] - BRAINTREE, Mass., Aug. 29, 2016 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that Gerry Gould, Vice President - Investor Relations, will present at The Baird 2016 Global Healthcare Conference ..."
HAE,HAE:US,BBG000C7TF41,Haemonetics to Present at The Baird 2016 Global Healthcare Conference,2016-08-29 20:15:00 +0000,http://finance.yahoo.com/news/haemonetics-present-baird-2016-global-201500912.html,"[PR Newswire] - BRAINTREE, Mass., Aug. 29, 2016 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that Gerry Gould, Vice President – Investor Relations, will present at The Baird 2016 Global Healthcare Conference ..."
HAE,HAE:US,BBG000C7TF41,"H1 2016: Sales growth 40% to EUR 142.27 million, EBIT-growth 40% to EUR 5.93 million, compared to prior year period",2016-08-29 08:13:07 +0000,http://www.publicnow.com/view/B5920730F582F59F071E3FCD52F935F440114AD7,"[at noodls] - H1 2016: Sales growth 40% to EUR 142.27 million, EBIT-growth 40% to EUR 5.93 million, compared to prior year period The text version of this document is not available at the moment. The original content ..."
HAE,HAE:US,BBG000C7TF41,Weekly CEO Buys Highlights,2016-08-15 23:08:58 +0000,http://finance.yahoo.com/news/weekly-ceo-buys-highlights-230858766.html,Weekly CEO Buys Highlights
HAE,HAE:US,BBG000C7TF41,"Tuesday 8/9 Insider Buying Report: EIGI, HAE",2016-08-09 16:32:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dsXHZ6g3HLc/tuesday-89-insider-buying-report-eigi-hae-cm662574,"Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard earned cash to make a"
HAE,HAE:US,BBG000C7TF41,Haemonetics CEO Completes Open Market Share Purchase,2016-08-08 20:28:15 +0000,http://www.publicnow.com/view/138AA919DC43EADBDEC394B4B202146BD742B3CC,"[at noodls] - BRAINTREE, Mass., Aug. 8, 2016 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) today announced that Christopher Simon, President and CEO, has acquired 60,000 shares of the Company's common stock at ..."
HAE,HAE:US,BBG000C7TF41,"ETF’s with exposure to Haemonetics Corp. : August 5, 2016",2016-08-05 19:07:50 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-haemonetics-corp-august-5-2016/,"ETF’s with exposure to Haemonetics Corp. : August 5, 2016"
HAE,HAE:US,BBG000C7TF41,"Haemonetics Corp. :HAE-US: Earnings Analysis: Q1, 2017 By the Numbers : August 4, 2016",2016-08-04 15:35:41 +0000,http://www.capitalcube.com/blog/index.php/haemonetics-corp-hae-us-earnings-analysis-q1-2017-by-the-numbers-august-4-2016/,"Haemonetics Corp. :HAE-US: Earnings Analysis: Q1, 2017 By the Numbers : August 4, 2016"
HAE,HAE:US,BBG000C7TF41,"Haemonetics (HAE) Lags Q1 Earnings, Tops Sales Estimates",2016-08-02 21:57:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DA9l6INL8vw/haemonetics-hae-lags-q1-earnings-tops-sales-estimates-cm659175,"Haemonetics CorporationHAE reported adjusted earnings per share (EPS) of 25 cents in the first quarter of fiscal 2017, missing the Zacks Consensus Estimate by 10.7%. Moreover, adjusted EPS dropped 29% from the year ago quarter. Per management, two factors"
HAE,HAE:US,BBG000C7TF41,"Haemonetics (HAE) Lags Q1 Earnings, Tops Sales Estimates",2016-08-02 19:33:07 +0000,http://finance.yahoo.com/news/haemonetics-hae-lags-q1-earnings-193307835.html,"Haemonetics (HAE) Lags Q1 Earnings, Tops Sales Estimates"
HAE,HAE:US,BBG000C7TF41,Haemonetics Reaches Analyst Target Price,2016-08-02 14:51:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tDZffZo0xaQ/haemonetics-reaches-analyst-target-price-cm658714,"In recent trading, shares of Haemonetics Corp. (Symbol HAE) have crossed above the average analyst 12 month target price of $31.67, changing hands for $33.52 share. When a stock reaches the target an analyst has set, the analyst logically"
HAE,HAE:US,BBG000C7TF41,Strength seen in Haemonetics (HAE): Stock Soars 10.5%,2016-08-02 13:57:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/n8QAf2YUJOI/strength-seen-in-haemonetics-hae-stock-soars-105-cm658767,"Haemonetics CorporationHAE was a big mover last session, as the company saw its shares rise over 11% on the day. The upside was driven after the company announced first quarter fiscal 2017 results. The news also led to far"
HAE,HAE:US,BBG000C7TF41,Strength seen in Haemonetics (HAE): Stock Soars 10.5%,2016-08-02 12:30:12 +0000,http://finance.yahoo.com/news/strength-seen-haemonetics-hae-stock-123012269.html,Strength seen in Haemonetics (HAE): Stock Soars 10.5%
HAE,HAE:US,BBG000C7TF41,Edited Transcript of HAE earnings conference call or presentation 1-Aug-16 12:00pm GMT,2016-08-01 19:47:00 +0000,http://finance.yahoo.com/news/edited-transcript-hae-earnings-conference-194700097.html,Edited Transcript of HAE earnings conference call or presentation 1-Aug-16 12:00pm GMT
HAE,HAE:US,BBG000C7TF41,Haemonetics (HAE) Shares Cross Above 200 DMA,2016-08-01 16:52:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BqQ68il276U/haemonetics-hae-shares-cross-above-200-dma-cm658113,"In trading on Monday, shares of Haemonetics Corp. (Symbol HAE) crossed above their 200 day moving average of $31.45, changing hands as high as $33.11 per share. Haemonetics Corp. shares are currently trading up about 6.5% on the day."
HAE,HAE:US,BBG000C7TF41,Haemonetics Corp Earnings Call scheduled for 8:00 am ET today,2016-08-01 12:00:00 +0000,http://biz.yahoo.com/cc/4/152894.html,Haemonetics Corp Earnings Call scheduled for 8:00 am ET today
HAE,HAE:US,BBG000C7TF41,Q1 2017 Haemonetics Corp Earnings Release - 06:00 am ET,2016-08-01 11:07:01 +0000,http://biz.yahoo.com/research/earncal/20160801.html?t=hae,Q1 2017 Haemonetics Corp Earnings Release - 06:00 am ET
HAE,HAE:US,BBG000C7TF41,Haemonetics 1st Quarter Fiscal 2017 Earnings Release Available on Investor Relations Website,2016-08-01 10:21:11 +0000,http://www.publicnow.com/view/07BB9EECDE7D3F177385F47E5D6EB5BBF209B552,"[at noodls] - BRAINTREE, Mass., Aug. 1, 2016 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) today announced fiscal year 2017 first quarter financial results are available on its Investor relations website. The Company ..."
HAE,HAE:US,BBG000C7TF41,Haemonetics Appoints Bill Burke CFO,2016-08-01 10:21:11 +0000,http://www.publicnow.com/view/6545C42CAAE41AE45FAD7DE947578A3B0D22906A,"[at noodls] - BRAINTREE, Mass., Aug. 1, 2016 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) today announced that William P. Burke will join the Company as Chief Financial Officer, effective August 8, 2016. In this ..."
HAE,HAE:US,BBG000C7TF41,Haemonetics reports 1Q loss,2016-08-01 10:16:12 +0000,http://sg.finance.yahoo.com/news/haemonetics-reports-1q-loss-101612519.html,Haemonetics reports 1Q loss
HAE,HAE:US,BBG000C7TF41,"HAEMONETICS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or Principal",2016-08-01 10:11:52 +0000,http://biz.yahoo.com/e/160801/hae8-k.html,"HAEMONETICS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or Principal"
HAE,HAE:US,BBG000C7TF41,Haemonetics Corp. (HAE) Has Climbed To A 3-Month High After Q1 Report,2016-08-01 09:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ReRQcypgO4c/haemonetics-corp-hae-has-climbed-to-a-3month-high-after-q1-report-20160801-00594,Haemonetics Corp. (HAE) Has Climbed To A 3-Month High After Q1 Report
HAE,HAE:US,BBG000C7TF41,Haemonetics Q1 17 Earnings Conference Call At 8:00 AM ET,2016-08-01 07:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zwOM-V0xDXI/haemonetics-q1-17-earnings-conference-call-at-800-am-et-20160801-00222,Haemonetics Q1 17 Earnings Conference Call At 8:00 AM ET
HAE,HAE:US,BBG000C7TF41,"Pre-Market Earnings Report for August 1, 2016 :  L, CNA, AMG, GRA, BWP, GWR, EDR, MCY, DO, ONB, NSP, HAE",2016-07-29 20:21:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/x39ZIntcuGw/pre-market-earnings-report-for-august-1-2016-l-cna-amg-gra-bwp-gwr-edr-mcy-do-onb-nsp-hae-cm657540,The following companies are expected to report earnings prior to market open on 08 01 2016. Visit our Earnings Calendar for a full list of expected earnings releases.  Loews Corporation ( L ) is reporting for
HAE,HAE:US,BBG000C7TF41,"HAEMONETICS CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders",2016-07-27 21:08:26 +0000,http://biz.yahoo.com/e/160727/hae8-k.html,"HAEMONETICS CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders"
HAE,HAE:US,BBG000C7TF41,"Haemonetics Corp. :HAE-US: Earnings Analysis: 2016 By the Numbers : July 26, 2016",2016-07-26 13:22:30 +0000,http://www.capitalcube.com/blog/index.php/haemonetics-corp-hae-us-earnings-analysis-2016-by-the-numbers-july-26-2016/,"Haemonetics Corp. :HAE-US: Earnings Analysis: 2016 By the Numbers : July 26, 2016"
HAE,HAE:US,BBG000C7TF41,"Haemonetics Sets Date for 1st Quarter Fiscal 2017 Earnings Release: August 1, 2016",2016-07-18 21:19:00 +0000,http://finance.yahoo.com/news/haemonetics-sets-date-1st-quarter-211900045.html,"[PR Newswire] - BRAINTREE, Mass., July 18, 2016 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) today announced that the Company will publish fiscal year 2017 first quarter financial results at 6:00am Eastern Time ..."
HAE,HAE:US,BBG000C7TF41,"HAEMONETICS CORP Files SEC form 8-K, Change in Directors or Principal Officers",2016-07-06 20:47:33 +0000,http://biz.yahoo.com/e/160706/hae8-k.html,"HAEMONETICS CORP Files SEC form 8-K, Change in Directors or Principal Officers"
HAE,HAE:US,BBG000C7TF41,"Haemonetics Corp. – Value Analysis (NYSE:HAE) : July 5, 2016",2016-07-05 16:11:39 +0000,http://www.capitalcube.com/blog/index.php/haemonetics-corp-value-analysis-nysehae-july-5-2016/,"Haemonetics Corp. – Value Analysis (NYSE:HAE) : July 5, 2016"
HAE,HAE:US,BBG000C7TF41,"Haemonetics Corp. breached its 50 day moving average in a Bullish Manner : HAE-US : July 1, 2016",2016-07-01 12:16:37 +0000,http://www.capitalcube.com/blog/index.php/haemonetics-corp-breached-its-50-day-moving-average-in-a-bullish-manner-hae-us-july-1-2016/,"Haemonetics Corp. breached its 50 day moving average in a Bullish Manner : HAE-US : July 1, 2016"
HAE,HAE:US,BBG000C7TF41,"Haemonetics Corp. breached its 50 day moving average in a Bullish Manner : HAE-US : June 21, 2016",2016-06-21 12:15:29 +0000,http://www.capitalcube.com/blog/index.php/haemonetics-corp-breached-its-50-day-moving-average-in-a-bullish-manner-hae-us-june-21-2016/,"Haemonetics Corp. breached its 50 day moving average in a Bullish Manner : HAE-US : June 21, 2016"
HAE,HAE:US,BBG000C7TF41,"Haemonetics: Q4 Hit by Issues in Russia, Currency Woes Stay",2016-06-09 16:19:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7WA5q_JkYnY/haemonetics-q4-hit-by-issues-in-russia-currency-woes-stay-cm632959,"On Jun 9, we issued an updated research report on Braintree, MA based HaemoneticsCorporationHAE , a global provider of blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers. The company currently carries a"
HAE,HAE:US,BBG000C7TF41,Haemonetics To Present At Jefferies Healthcare Conference; Webcast At 1:30 PM ET,2016-06-09 12:32:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GHMXQ_m_YHI/haemonetics-to-present-at-jefferies-healthcare-conference-webcast-at-130-pm-et-20160609-00689,Haemonetics To Present At Jefferies Healthcare Conference; Webcast At 1:30 PM ET
HAE,HAE:US,BBG000C7TF41,"Invetech, Haemonetics, and Coramed Technologies Receive 2016 Good Design Award® for Development of the TEG® 6s",2016-06-01 13:13:11 +0000,http://www.publicnow.com/view/9060337CEACF6BBE64452B8AFAF509513F8CBE50,[at noodls] - New hemostasis analysis system allows clinicians to better maintain a patient's coagulation equilibrium using unique all-in-one design. ... This is an abstract of the original noodl. To continue reading ...
HAE,HAE:US,BBG000C7TF41,"Q1 2016: Sales growth 50% to EUR 67.94 million, EBIT-growth 100% to EUR 3.47 million,compared to prior year Q1 period",2016-05-26 12:57:06 +0000,http://www.publicnow.com/view/8D330BD5A0DBFFD1E1851E268D2656F39F7A8B37,"[at noodls] - In the first quarter 2016 HAEMATO AG, Berlin (ISIN: DE0006190705), achieved IFRS Group sales of EUR 69.94 million (prior year period: EUR 45.16 million), an operating result (EBIT) of EUR 3.47 million ..."
HAE,HAE:US,BBG000C7TF41,Haemonetics to Present at Jefferies 2016 Healthcare Conference,2016-05-26 12:17:03 +0000,http://www.publicnow.com/view/A30ABCA0DA4CD6895643CC9B725B7F57595C0E26,"[at noodls] - BRAINTREE, Mass., May 26, 2016 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that Gerry Gould, Vice President - Investor Relations, will present at the Jefferies 2016 Healthcare Conference ..."
HAE,HAE:US,BBG000C7TF41,2015: Preliminary IFRS results,2016-05-26 10:47:07 +0000,http://www.publicnow.com/view/46135953185ADB68E166F0CA22361DE9389B0015,"[at noodls] - In the financial year 2015 HAEMATO AG, Berlin (ISIN: DE0006190705), achieved IFRS Group sales of EUR 229.7 million (prior year: EUR 202.7 million) and an operating result (EBIT) of EUR 8.2 million (prior ..."
HAE,HAE:US,BBG000C7TF41,"Q1 2016: Sales growth 50% to EUR 67.94 million, EBIT-growth 100% to EUR 3.47 million, compared to prior year Q1 period",2016-05-26 09:37:06 +0000,http://www.publicnow.com/view/B23137ED93CECC3F0FE43315BD16F931C7588766,"[at noodls] - In the first quarter 2016 HAEMATO AG, Berlin (ISIN: DE0006190705), achieved IFRS Group sales of EUR 69.94 million (prior year period: EUR 45.16 million), an operating result (EBIT) of EUR 3.47 million ..."
HAE,HAE:US,BBG000C7TF41,Haemonetics Corporation Announces Christopher Simon as President and Chief Executive Officer,2016-05-09 21:28:03 +0000,http://www.publicnow.com/view/1DB62F025382EB104FEE568FB7C5D377D0EC32C0,"[at noodls] - BRAINTREE, Mass., May 9, 2016 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) a global healthcare company dedicated to providing innovative solutions to our customers, today, announced the appointment ..."
HAE,HAE:US,BBG000C7TF41,Haemonetics Provides Fiscal 2017 Guidance,2016-05-09 21:28:03 +0000,http://www.publicnow.com/view/3A5A33612E727C5EC632E2667D1CB5CB257E6369,"[at noodls] - BRAINTREE, Mass., May 9, 2016 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) provided guidance for its fiscal year ending April 1, 2017. The Company follows a fiscal year reporting convention, ending ..."
HAE,HAE:US,BBG000C7TF41,"Haemonetics (HAE) Lags Q4 Earnings, Sales; Margins Drop",2016-05-03 12:52:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Hz-_Bnop6hg/haemonetics-hae-lags-q4-earnings-sales-margins-drop-cm615124,"Haemonetics CorporationHAE reported adjusted earnings per share (EPS) of 37 cents in the fourth quarter of fiscal 2016, missing the Zacks Consensus Estimate by 19.6%. Moreover, adjusted EPS dropped 21% from the year ago quarter. On a reported basis,"
HAE,HAE:US,BBG000C7TF41,"Why Baidu, Pandora Media, and Haemonetics Slumped Today",2016-05-02 23:49:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xGs3frAjSRk/why-baidu-pandora-media-and-haemonetics-slumped-today-cm615012,"Monday was a positive day on Wall Street, and the stock market bounced back from losses to close last week. The Dow picked up a triple digit daily gain, and most broad based market"
HAE,HAE:US,BBG000C7TF41,"Health Care Sector Update for 05/02/2016: HAE,AEMD,BIND",2016-05-02 18:48:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YffuPIP0xqg/health-care-sector-update-for-05022016-haeaemdbind-cm614859,"Top Health Care Stocks JNJ +0.26% PFE 0.31% MRK 0.24% ABT +0.38% AMGN 0.02% Health care stocks were narrowly higher today, with the NYSE Health Care Index rising about 0.1% while shares of health care companies in the S&P"
HAE,HAE:US,BBG000C7TF41,Haemonetics reports 4Q loss,2016-05-02 10:31:50 +0000,http://sg.finance.yahoo.com/news/haemonetics-reports-4q-loss-103150067.html,Haemonetics reports 4Q loss
HAE,HAE:US,BBG000C7TF41,"Haemonetics Reports 4th Quarter Fiscal 2016 Revenue of $243 Million, Constant Currency Revenue Growth of 10% and 7% As Reported; Fiscal 2016 Revenue of $910 Million, Constant Currency Revenue Growth of 3% and Flat As Reported",2016-05-02 10:20:08 +0000,http://www.publicnow.com/view/9935960342148856739771821B98E3360DF70237,"[at noodls] - BRAINTREE, Mass., May 2, 2016 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) reported fourth quarter fiscal 2016 revenue of $243.2 million, up 7%. Revenue was up 10% over the fourth quarter of fiscal ..."
HAE,HAE:US,BBG000C7TF41,"Pre-Market Earnings Report for May 2, 2016 :  SYY, L, CNA, HP, EEP, BWP, DO, MCY, INCR, EDR, PCRX, HAE",2016-04-29 20:19:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6K9JhndQioM/pre-market-earnings-report-for-may-2-2016-syy-l-cna-hp-eep-bwp-do-mcy-incr-edr-pcrx-hae-cm614147,The following companies are expected to report earnings prior to market open on 05 02 2016. Visit our Earnings Calendar for a full list of expected earnings releases.  Sysco Corporation ( SYY ) is reporting for
HAE,HAE:US,BBG000C7TF41,Haemonetics Honored for Delivering 'World-Class' Customer Service,2016-04-29 16:32:47 +0000,http://www.publicnow.com/view/102F55119919214D6FD77F0B99EFAD5622D293A7,"[at noodls] - BRAINTREE, Mass., April 29, 2016 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that it has received the NorthFace ScoreBoard Award from Omega Management Group Corp. in recognition ..."
HAE,HAE:US,BBG000C7TF41,Haemonetics Announces CFO's Retirement,2016-04-14 20:25:30 +0000,http://www.publicnow.com/view/6D5FBD89C1D00BB669135EFCB0E10FF348B99754,"[at noodls] - BRAINTREE, Mass., April 14, 2016 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that Christopher Lindop, Chief Financial Officer and Executive Vice President, Business Development ..."
HAE,HAE:US,BBG000C7TF41,"Haemonetics Sets Date for 4th Quarter and Fiscal 2016 Earnings Release: May 2, 2016",2016-04-07 20:08:08 +0000,http://www.publicnow.com/view/E53AA73CD438B76B3F241D89EF6D48A4D1875B42,"[at noodls] - BRAINTREE, Mass., April 7, 2016 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company will report its results for the fourth quarter and fiscal year 2016 on Monday, May 2, 2016 ..."
HAE,HAE:US,BBG000C7TF41,"Haemonetics Sets Date for Investor/Analyst Meeting - May 10, 2016",2016-04-05 20:27:23 +0000,http://www.publicnow.com/view/20B878B5D98E654EFE4C55E80FD692FF0E2F362A,"[at noodls] - BRAINTREE, Mass., April 5, 2016 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that it will host its annual investor and analyst meeting on Tuesday, May 10 from 9:00am to 2:30pm at ..."
HAE,HAE:US,BBG000C7TF41,Haemonetics Breaks Above 200-Day Moving Average - Bullish for HAE,2016-03-29 21:25:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LKV7OI8Wg4g/haemonetics-breaks-above-200-day-moving-average-bullish-for-hae-cm599087,"In trading on Tuesday, shares of Haemonetics Corp. (Symbol HAE) crossed above their 200 day moving average of $34.71, changing hands as high as $34.74 per share. Haemonetics Corp. shares are currently trading up about 2.8% on the day."
HAE,HAE:US,BBG000C7TF41,"Mixed Q3 at Haemonetics, FY16 View Strong: Hold Now",2016-03-08 21:36:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1DnZmrn-_p4/mixed-q3-at-haemonetics-fy16-view-strong-hold-now-cm590097,"On Mar 7, 2016, we issued an updated research report on Massachusetts based Haemonetics CorporationHAE , a provider of blood management solutions to blood and plasma collectors, hospitals and health care providers globally. Haemonetics ended third quarter fiscal 2016"
HAE,HAE:US,BBG000C7TF41,"Haemonetics Tops Q3 Earnings, Lags Revenues; Keeps View",2016-02-02 18:17:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Tvx4omfDAcI/haemonetics-tops-q3-earnings-lags-revenues-keeps-view-cm573643,"Haemonetics CorporationHAE reported adjusted earnings per share (EPS) of 48 cents in the third quarter of fiscal 2016, exceeding the Zacks Consensus Estimate by a penny. However, adjusted EPS dropped 9% from the year ago quarter. On a reported"
HAE,HAE:US,BBG000C7TF41,"Haemonetics Reports 3rd Quarter Fiscal 2016 Revenue of $233 Million, Constant Currency Revenue Growth of 4% and 1% As Reported",2016-02-01 11:20:01 +0000,http://www.publicnow.com/view/5AC580D014A272382A2CC3DEC560D6803D7330F9,"[at noodls] - , /PRNewswire/ -- Revenue Growth Highlights The constant currency revenue increase in the third quarter included strong performance from identified growth drivers: 14% growth in Plasma disposables revenue ..."
HAE,HAE:US,BBG000C7TF41,Haemonetics reports 3Q loss,2016-02-01 11:12:38 +0000,http://sg.finance.yahoo.com/news/haemonetics-reports-3q-loss-111238379.html,Haemonetics reports 3Q loss
HAE,HAE:US,BBG000C7TF41,"Pre-Market Earnings Report for February 1, 2016 :  AET, CAH, SYY, ROP, HRC, SOHU, HAE, ONB, SNBC, OFG, CYOU, TBBK",2016-01-29 21:24:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-Be0K-T682Y/pre-market-earnings-report-for-february-1-2016-aet-cah-syy-rop-hrc-sohu-hae-onb-snbc-ofg-cyou-tbbk-cm572396,The following companies are expected to report earnings prior to market open on 02 01 2016. Visit our Earnings Calendar for a full list of expected earnings releases.  Aetna Inc. ( AET ) is reporting for
HAE,HAE:US,BBG000C7TF41,"Haemonetics Sets Date for 3rd Quarter Fiscal 2016 Earnings Release: February 1, 2016",2016-01-07 21:10:11 +0000,http://www.noodls.com/view/62197EDDC236E94E8FF31D000ACC48AF9D2D6D8F,"[at noodls] - , /PRNewswire/ -- (NYSE: HAE) today announced that the Company will report its results for the third quarter of fiscal year 2016 on in a pre-market press release. The Company will hold a webcast conference ..."
HAE,HAE:US,BBG000C7TF41,Cerus Announces Collaboration Agreement With Haemonetics for the Use of Acrodose Platelet Kits With the INTERCEPT Blood System for Platelets,2015-12-02 13:49:46 +0000,http://www.noodls.com/view/17B1E1C2D493255205FEFDD37CB88CA4E31949FC,"[at noodls] - CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (NASDAQ:CERS) announced today that it has entered into an agreement with Haemonetics Corporation (NYSE:HAE) for the sale of Haemonetics' Acrodose Platelet ..."
HAE,HAE:US,BBG000C7TF41,Q3 2015: 43 % sales increase in Q3 2015 compared to the prior-year quarter,2015-11-27 07:35:17 +0000,http://www.noodls.com/view/52148D25FEA95775908FB9005C7272854922CCEB,"[at noodls] - In the first 9 months of 2015 HAEMATO AG, Berlin (ISIN: DE0006190705), achieved IFRS sales of EUR 161.99 million and profit of EUR 4.49 million. In the third quarter alone, sales amounted to EUR 60.52 ..."
HAE,HAE:US,BBG000C7TF41,Haemonetics to Present at the Jefferies 2015 Global Healthcare Conference,2015-11-11 22:56:12 +0000,http://www.noodls.com/view/4FC6B5A9A74DD5D69B75D5DED743F99468CEE5A5,"[at noodls] - BRAINTREE, Mass., Nov. 11, 2015 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that Gerry Gould, Vice President, Investor Relations, will present at the Jefferies 2015 Global Healthcare ..."
HAE,HAE:US,BBG000C7TF41,Haemonetics beats 2Q profit forecasts,2015-11-04 11:27:31 +0000,http://sg.finance.yahoo.com/news/haemonetics-beats-2q-profit-forecasts-112731046.html,Haemonetics beats 2Q profit forecasts
HAE,HAE:US,BBG000C7TF41,Haemonetics beats 3Q profit forecasts,2015-01-29 14:09:54 +0000,http://sg.finance.yahoo.com/news/haemonetics-beats-3q-profit-forecasts-140954728.html,Haemonetics beats 3Q profit forecasts
